{
    "fullText": "S1 Supporting Information for  A multidomain P450 epoxidase and a terpene cyclase from ascochlorin biosynthetic pathway in Fusarium sp.  Zhiyang Quan,\u2020,# Takayoshi Awakawa,*,\u2020,\t\u22a5,# Dongmei Wang,\u2020, \u2021,# Yue Hu,\u2021 and Ikuro Abe*,\u2020, \u22a5  \u2020 Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan \u22a5 Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan \u2021 School of Pharmaceutical Sciences, Sun Yat-sen University, No. 135, Xingang Xi Road, Guangzhou, 510275, P. R. China    Table of Contents Supplementary Material and Methods S2-S9 Supplementary Tables S1-S6 S10-S15 Supplementary Figures S1-S42 S16-S42 Supplementary References S43  S2 Supplementary Materials and Methods  General Solvents and chemicals were purchased from Wako Chemicals Ltd. (Tokyo, Japan) or Kanto Chemical Co., Inc. (Tokyo, Japan), unless noted otherwise. Oligonucleotide primers were purchased from Eurofins Genetics (Tokyo, Japan), and Sigma Aldrich Japan Genosys (Table S1). PCR was performed using a TaKaRa PCR Thermal Cycler Dice\u00ae Gradient (TaKaRa), with KOD FX Neo (TOYOBO) or iProof DNA polymerase (BIO-RAD). Ligations of DNA fragments were performed using an in-Fusion HD cloning kit (Clontech). Sequence analyses were performed by Eurofins Genetics (Tokyo). Total mRNA isolation of Fusarium sp. NBRC100844 was performed utilizing ISOGEN Reagent (NIPPON GENE CO., LTD.). Reverse transcription of mRNA was performed utilizing a SuperScript\u2122 III First-Strand Synthesis System (Thermo Fisher Scientific Inc.). Silica gel column chromatography was performed using Silica Gel 60 N (spherical, neutral, 40-50 \u03bcm) (Kanto Chemical Co., Inc.). Analytical and preparative HPLC were performed on a Shimadzu Prominence system, using a an ODS-80TM column (4.6 i.d. x 150 mm, Tosoh Co. Ltd.) and an ODS-80TM column (7.8 i.d. x 300 mm, Tosoh Co. Ltd.). Samples for LC-MS analysis were injected into an Shimadzu Prominence system HPLC-MicroTOF mass spectrometer (Bruker Daltonics), using electrospray ionization with a COSMOSIL 2.5C18-MS-II column (2.0 i.d. x 75 mm; Nacalai Tesque, Inc.). NMR spectra were obtained at 500 MHz (1H) and 125 MHz (13C) with a JEOL ECX-500 or ECZ-500 spectrometer, and chemical shifts were recorded with reference to solvent signals (1H NMR: CDCl3 7.26 ppm; 13C NMR: CDCl3 77.0 ppm).\tOptical rotation of each metabolite was measured utilizing DIP-1000 digital polarimeter (JASCO). The ascochlorin producing strain, Fusarium sp. NBRC100844 was purchased from NITE. Draft genome sequencing and assembling of Fusarium sp. NBRC100844 was ordered from Macrogen Japan (Kyoto, Japan). Gene prediction was performed by AUGUSTUS (http://bioinf.uni-greifswald.de/webaugustus/). The glufosinate solution for the fungal transformation was extracted from Basta (Bayer), as previously described,1 and used at a 50 \u00b5L/mL concentration.  Plasmids construction and fungal transformation Aspergillus oryzae NSAR1 (niaD-, sC-, \u0394argB, adeA-) and fungal transformation vector pTAex3, pUSA, pUNA, and pAdeA are kindly provided by Prof. K. Gomi (Graduate School of Agricultural Sciences, Tohoku University) and Prof. K. Kitamoto (Graduate School of Agricultural Sciences, The University of Tokyo).2 pPTRI vector was purchased from TAKARA.3 pBARI vector was constructed based on pPTRI as previously reported.4 Fungal transformation was performed by the protoplast\u2013polyethylene glycol method, as reported previously.5 1. Plasmids construction Primers for fungal expression plasmids construction used in this research were listed in Table S1. The S3 procedures of plasmids construction were summarized in Table S2, and all the ligations are performed utilizing a in-Fusion HD cloning kit. 2. Fungal transformation A. oryzae transformants constructed for this study and their construction procedures are summarized in Table S3.  Constructions of plasmids for in vitro assay and mutagenesis study Primers for in vitro assay and mutagenesis study were listed in Table S4. Ligations of pET28a-AscD, pColdII-AscE, and pESC-URA-AscF were summarized in Table S5. Point mutation of AscF was performed using PCR method. The reaction solution of PCR was digested with DpnI (TAKARA) and purified to linear DNA. The linear DNA was introduced to DH5\u03b1 (Clontech) to yield plasmid for mutation. The information of mutation plasmid construction was summarized in Table S5.  Preparation of the protein lysate containing AscD from in E. coli E. coli RosettaII (DE3) pLysS cells harboring pET28a-AscD were cultured to an OD600 of 0.7 in LB media containing 50\u2009\u03bcg\u2009ml-1 kanamycin and 34 \u03bcg\u2009ml-1 chloramphenicol at 37\u2009\u00b0C. Isopropyl \u03b2-D-1-thiogalactopyranoside was then added to a final concentration of 0.4\u2009mM to induce gene expression, and the cultures were incubated further for 16\u2009h at 15\u2009\u00b0C. The 200 mL E. coli cells were harvested by centrifugation at 5,000\u2009g and resuspended in 4 mL buffer A [50\u2009mM Tris\u2013HCl buffer pH 7.5, containing 300\u2009mM NaCl, 1 mM EDTA, and 2 mM DTT]. The cells were disrupted by sonication and the lysate was centrifuged at 12,000\u2009g for 15\u2009min. The soluble protein lysate was concentrated into 0.5 mL, and used for the assay immediately.  Preparation of the protein lysate containing AscE from in E. coli E. coli RosettaII (DE3) pLysS cells harboring pColdII-AscE were cultured to an OD600 of 0.5 in ZYM-5052 auto-inducing medium (F. W. Studier, Structural Genomics, Methods in Molecular Biology, Vol.1091, pp 17-32, (2013)) containing 50\u2009\u03bcg\u2009ml-1 kanamycin and 100 \u03bcg\u2009ml-1 ampicillin at 37\u2009\u00b0C. Isopropyl \u03b2-D-1-thiogalactopyranoside, aminolevlic acid, and Fe(SO4)2(NH4)2\uff656H2O was then added to a final concentration of 0.05\u2009mM, 225 \u03bcg/mL, and 300 \u03bcM to induce gene expression and biosynthesis of heme, and the cultures were incubated further for 16\u2009h at 15\u2009\u00b0C. The 50 mL E. coli cells were harvested by centrifugation at 5,000\u2009g and resuspended in 5 mL buffer B [50\u2009mM Tris\u2013HCl buffer pH 8.0, containing 200\u2009mM NaCl, 20% (v/v) glycerol, and Complete Ultra Tablets Mini EDTA-free (Roche)]. The cells were disrupted by sonication and the lysate was centrifuged at 12,000\u2009g for 15\u2009min. The reddish soluble protein lysate was concentrated into 2.0 mL, and used for the assay immediately.  Preparation of microsome fraction containing AscF from yeast S4 pESC-URA-AscF was introduced into Saccharomyces cerevisiae INVSC1 (invitrogen) with Frozen-EZ Yeast transformation II (Zymo research). The transformant was inoculated into 10 mL Synthetic dextrose (SD)-Ura medium, and incubated at 30 \u00baC for 2 days as Preculture1. Preculture1 was transferred into 500 mL SD-Ura medium, and incubated at 30 \u00baC in 1 day as Preculture2. The cells in Preculture2 was centrifuged, resuspended with Synthetic Glactose (SG)-Ura medium, and transferred into 500 mL SG-Ura medium, and incubated at 30 \u00baC for 1 day. Cells from 250 mL culture were harvested, resuspended in 10 mL of 0.1 M KPB (pH 7.4) and disrupted with glass beads. After centrifugation (10,000 g) to remove the cell debris, ultracentrifugation (100,000 g) was carried out fort 1 hour to collect the microsome fraction which was suspended in 500 \u03bcL of 0.1 M KPB (pH 7.4) with 24 mM CHAPS.  Assay of AscD reaction For assay of AscD, 200 \u03bcM FAD+, 20 mM NADH, 200 \u03bcM 2 or 5 were incubated with the soluble protein lysate from AscD-expressing culture with total 50 \u03bcL scale for 30 \u00baC in 400 min, and the reaction was extracted with 500 \u00b5L of EtoAc, and the extract was evaporated in vacuo. 50 \u03bcL of methanol was added into the extract, and 20 \u03bcL was analyzed with HPLC.  Assay of AscEF reaction CO spectra assay for AscE was performed as the literature. For assay of AscE, 200 \u03bcM FAD+, 10 mM NADPH, 200 \u03bcM 2 (or 5-farnesyl-6-hydroxymellein) were incubated with the soluble protein lysate from AscE-expressing culture with total 50 \u03bcL scale for 30 \u00baC in 12 hr, and 25 \u03bcL of the microsome fraction containing AscF was added into the reaction. After additional 12 hr incubation, enzymes in the assay were precipitated by addition of 50 \u03bcL methanol and centrifugation. 20 \u03bcL of the reaction was analyzed with HPLC.  Synthesis and preperation of racemic 46 1. Preparation of bromohydrin-2 a) Synthesis of bromohydrin-2 from 2  Compound 2 (3.5 mg, 10 \u03bcmol) was dissolved in THF (372 \u03bcL) and H2O (105 \u03bcL), then the solution was left on ice-water mixture while stiring until the temperature of the whole system fell to 0 \u00baC. Recrystallized N-bromosuccinimide (NBS, 0.6 mg, 3 \u03bcmol) was added to solution of 2, and stirred for 30 min at 30 \u00baC. This operation was repeated for 6 times. Then, the reaction mixture was subjected to a N Br O O N-bromosuccinimideCHO OH HO 2 THF, H2O, at 273 KCHO OH HO HO Br bromohydrin-2 S5 semi-preparative HPLC at once to isolate bromohydrin-2 as clear oil. b) Isolation of bromohydrin-2 The mixture was subjected to a reverse-phase preparative HPLC, with a solvent system of milliQ (solvent A) and acetonitrile (solvent B), at a flow rate of 3.5 mL/min and a column temperature at 40 \u00baC. Isolation was started with solvent B/solvent A (85:15), then a linear gradient from B/A (85:15) to B/A (100:0) within the following 5 min, B/A (100:0) for an additional 1min. Bromohydrin-2 was yielded as clear oil. 6 trials (compound 2 at a total weight of 21 mg, 60 \u03bcmol) was conducted at the same time in order to accumulate enough bromohydrin-2, the precursor of racemic 4.  2. Synthesis of racemic 4 a) Dehydrochlorination of bromohydrin-2  Bromohydrin-2 prepared in last step was added into a slurry of methanol (2 mL) and K2CO3 (50 mg, 360 \u03bcmol), and stirred for 30 min at room temperature to yield racemic 4. b) Purification of racemic 4 The reaction slurry containing racemic 4 was evaporated to remove the methanol firstly, and the residue was extracted with ethyl acetate from water. The extract was subjected to a silica-gel column chromatography and eluted using hexane:ethyl acetate (1:9) to yield racemic 4 (1.7 mg, 4.6 \u03bcmol) as a clear oil.  The mosher analysis of cylindrocarpol (4\u2019)7 1. Synthesis of 4-O-methylated-4\u2019  A mixture of 4\u2019 (2.0 mg), MeI (20 \u03bcl), and K2CO3 (20 mg) in 2-butanone (0.3 ml) was stirred at room temperature for 15 h. The reaction mixture was diluted with EtOAc (5 ml) and washed with H2O (5 ml) twice, and the organic layer was collected and concentrated to afford the methylated derivative (2.0 mg, pale yellow oil).  OH HO CHOHO Br OH HO CHO O bromohydrin-2 racemic 4K2CO3 methanol at room temperature5 4 3 2 1 6 9 10 11 12 13 14 15 16 17 18 1920 232221 CHO 8 OH 7 HO cylindrocarpol (4\u2019)HO OH CHO OH MeO HO OH 4-O-methylated-4\u2019 MeI, K2CO32-butanone at room S6 1H NMR (partial assignment, 500 MHz, CDCl3) 12.4 (1H, s, 6-OH), 10.1 (1H, s, H-8), 6.28 (1H, s, H-3), 5.17 (1H. m, H-10), 5.16 (1H, m, H-14), 3.89 (3H, s, 4-OMe), 3.34 (1H, m, H-18), 3.30 (2H, m, H-9), 2.56 (3H, s, H-7), 2.09 (2H, m, H-16), 2.02 (2H, m, H-13), 1.96 (2H, m, H-12), 1.76 (3H, brs, H-23), 1.59 (3H, brs, H-22), 1.41, 1.58 (2H, m, H-17), 1.19 (3H, brs, H-20), 1.14 (3H, brs, H-21).  Synthesis of S-mosher diester of 4-O-methylated-4\u2019  4-O-methylated-4\u2019 (1.0 mg) was dissolved in pyridine (0.3 ml, dehydrated) and treated with excess amount of (-)-(R)-MTPA-Cl (10\u03bcl) at room temperature for 1 h. The reaction mixture was diluted with EtOAc and washed with H2O and saturated NaHCO3. The organic layer was concentrated and purified by preparative HPLC (isocratic in 100% CH3CN) to afford a S-mosher diester of 4-O-methylated-4\u2019 (ca. 0.5 mg).  1H NMR (partial assignment, 500 MHz, CDCl3) 9.99 (1H, s, H-8), 6.64 (1H, s, H-3), 5.00 (1H, m, H-14), 4.97 (1H, m, H-18), 4.95 (1H, m, H-10), 3.89 (3H, s, 4-OMe), 3.66 (3H, s, 4-Mosher-OMe or 6-Mosher-OMe), 3.56 (3H, s, 4-Mosher-OMe or 6-Mosher-OMe), 3.10 (2H, m, H-9), 2.63 (3H, s, H-7), 1.99 (2H, m, H-13), 1.91 (2H, m, H-12), 1.83 (2H, m, H-16), 1.62 (3H, s, H-23), 1.56, 1.66 (2H, m, H-17), 1.49 (3H, s, H-22), 1.20 (3H, brs, H-20), 1.14 (3H, brs, H-21).  2. Synthesis of R-mosher diester of 4-O-methylated-4\u2019  In the same manner, 4-O-methylated-4\u2019 (1.0 mg) was treated with excess amount of (+)-(S)-MTPA-Cl (10 CHO OH MeO HO OH 4-O-methylated-4\u2019 (-)-(R)-MTPA-Cl pyridine at room temperatureOO H O (R) O HO (S) O CF3 OCH3 (S) OH3CO F3C S-mosher diester of 4-O-methylated-4\u2019CHO OH MeO HO OH 4-O-methylated-4\u2019 (-)-(S)-MTPA-Cl pyridine at room temperatureR-mosher diester of 4-O-methylated-4\u2019OO H O (R) O HO (R) O OCH3 CF3 (R) OF3C H3CO S7 \u03bcl) at room temperature for 1 h. The reaction mixture was diluted with EtOAc and washed with H2O and saturated NaHCO3. The organic layer was concentrated and subjected to NMR analysis without purification.  1H NMR (partial assignment, 500 MHz, CDCl3) 9.99 (1H, s, H-8), 6.64 (1H, s, H-3), 5.04 (1H, m, H-14), 4.96 (1H, m, H-18), 4.75 (1H, m, H-10), 3.88 (3H, s, 4-OMe), 3.66 (3H, s, 4-Mosher-OMe or 6-Mosher-OMe), 3.57 (3H, s, 4-Mosher-OMe or 6-Mosher-OMe), 3.11 (2H, m, H-9), 2.63 (3H, s, H-7), 2.01 (2H, m, H-13), 1.93 (2H, m, H-16), 1.92 (2H, m, H-12), 1.63,1.71 (2H, m, H-17), 1.62 (3H, brs, H-23), 1.53 (3H, brs, H-22), 1.15 (3H, brs, H-20), 1.11 (3H, brs, H-21).  Analytical conditions Metabolites from the Aspergillus oryzae transformants and Fusarium sp. NBRC100844 were analyzed by HPLC, with a solvent system of 0.1% formic acid (solvent A) and acetonitrile containing 0.1% formic acid (solvent B), at a flow rate of 1.0 ml/min and a column temperature of 40 \u00b0C. Separation was performed with solvent B/solvent A (50:50), a linear gradient from 50:50 to 80:20 within the following 15 min, a linear gradient from 80:20 to 100:0 within the following 5 min, 100:0 for 5 additional min.  Isolation of the metabolites from Fusarium sp. NBRC100844 Fusarium sp. was cultured at 30 \u00baC for 7 days in 2 L flasks containing 1 L DPY medium. After filtering, the mycelia were lyophilized to dryness. Dried mycelia were extracted by acetone. The extraction solution was concentrated in vacuo to remove the solvent. The extract (146 mg) was subjected to silica-gel column chromatography and eluted stepwise using a hexane:acetone gradient (100:0 to 70:30). Fractions containing 6, 5, 1a, and 7a were further purified by reverse-phase preparative HPLC equipped with an Ultimate AQ-C18 column (Welch Inc., Ellicott, MO, USA, 5 \u03bcm, 10 mm i.d. x 250 mm) using acetonitrile-water (70:30) as the eluting solvent (flow rate 3.0 mL/min) to yield 5 (2.1 mg), 6 (3.8 mg), 1a (24.9 mg) and 7a (10.1 mg). For, 1b and 7b, Fusarium sp. was cultured at 30oC for 7 days in two 2 L flasks containing 1 L CD-NaBr medium (NaNO3 0.3%, K2HPO4 0.1%, MgSO4\u30fb7H2O 0.05%, FeSO4\u30fb7H2O 0.002%, Glucose 2%, NaBr 0.35%, pH 5.5) for each flask. After filtering, the mycelia were lyophilized to dryness. Dried mycelia were extracted by acetone. The extraction solution was concentrated in vacuo to remove the solvent. The extract (720 mg) was subjected to silica-gel column chromatography and eluted stepwise using a hexane: acetone gradient (95:5 to 70:30). Fractions that contained 1b and 7b were further purified by reverse-phase preparative HPLC using acetonitrile-water (70:30) as the eluting solvent (flow rate 3.0 mL/min) to yield 1b (7.0 mg), 7b (35 mg).  Isolation of the metabolites accumulated in Aspergillus oryzae transformants  Isolation of AscABC product (2) from A. oryzae transformant S8 The extract from 3 L culture of A. oryzae NSAR1 harboring ascABC was subjected to silica-gel column chromatography and eluted using chloroform:methanol (100:0). Fractions that contained 2 yield 21.0 mg of a clear oil.  Isolation of AscABCEF product (5) from A. oryzae transformant The extract from 1 L culture of A. oryzae NSAR1 harboring ascABCEF was subjected to silica-gel column chromatography and eluted stepwise using a chloroform:methanol gradient (100:0 to 90:10). Fractions that contained 5 were further purified by reverse-phase preparative HPLC (40% aqueous acetonitrile, 3.0 mL/min) to yield 5.2 mg of a clear oil.  Isolation of AscABCE product (4\u2019) from A. oryzae transformant The extract from 1 L culture of A. oryzae NSAR1 harboring ascABCE and ascF (W130A, W131A) was subjected to silica-gel column chromatography and eluted stepwise using a chloroform:methanol gradient (100:0 to 90:10). Fractions that contained 4\u2019 were further purified by reverse-phase preparative HPLC (30% aqueous acetonitrile, 3.5 mL/min) to yield 5.0 mg of a clear oil.  Isolation of AscABCEFG product (6) from A. oryzae transformant The extract from 1 L culture of A. oryzae NSAR1 harboring ascABCEFG was subjected to silica-gel column chromatography and eluted stepwise using a chloroform:methanol gradient (100:0 to 90:10). Fractions that contained 6 were further purified by reverse-phase preparative HPLC (40% aqueous acetonitrile, 3.0 mL/min) to yield 0.1 mg of a white solid.  Summary of analytical data Ascochlorin (1a): White solid; for NMR data see Table S6 (S13) and Figures S18 and S19; HR-ESI-MS found m/z 403.1682 [M -H]-(calcd 403.1676 for C23H28O4Cl). The NMR data were in good agreement with the reported data.  3-Bromoascochlorin (1b): White solid; for NMR data see Table S6 (S13) and Figures S20 and S21; HR-ESI-MS found m/z 447.1176 [M -H]-(calcd 447.1171 for C23H28O4Br). The NMR data were in good agreement with the reported data.  dechloroascochlorin (6): White solid; for NMR data see Table S6 (S13) and Figures S22 and S23; HR-ESI-MS found m/z 369.2071 [M -H]-(calcd 369.2066 for C23H29O4). The NMR data were in good agreement with the reported data.  S9 12,13-dihydroascochlorin (7a): White solid; for NMR data see Table S6 (S14) and Figures S24 and S25; HR-ESI-MS found m/z 405.1838 [M -H]-(calcd 405.1833 for C23H30O4Cl). The NMR data were in good agreement with the reported data.  3-bromo-12,13-dihydroascochlorin (7b): White solid; for NMR data see Table S6 (S14) and Figures S26 and S27; HR-ESI-MS found m/z 449.1310 [M -H]-(calcd 449.1333 for C23H30O4Br). The NMR data were in good agreement with the reported data.  dechloro-12,13-dihydroascochlorin (5): White solid; for NMR data see Table S6 (S14) and Figures S28 and S29; HR-ESI-MS found m/z 371.2225 [M -H]-(calcd 371.2228 for C23H31O4). The NMR data were in good agreement with the reported data.  LL-Z1272\u03b2 (2): Clear oil; for NMR data see Table S6 (S15) and Figures S30 and S31; HR-ESI-MS found m/z 355.2259 [M -H]-(calcd 355.2279 for C23H31O3). The NMR data were in good agreement with the reported data.  cylindrocarpol (4\u2019): Clear oil; for NMR data see Table S6 (S15) and Figures S32 and S33; HR-ESI-MS found m/z 389.2307 [M -H]-(calcd 389.2333 for C23H33O5). The NMR data were in good agreement with the reported data.  4-O-methylated-4\u2019: pale yellow oil; for NMR data see \u201cThe mosher analysis of cylindrocarpol\u201d and Figures S34, S35, S36, S37 and S38; HR-ESI-MS found m/z 405.2625 [M + H]+ (calcd 405.2636 for C24H37O5).  S-mosher diester of 4-O-methylated-4\u2019: for partial NMR data see \u201cThe mosher analysis of cylindrocarpol\u201d and Figures S39 and S40; HR-ESI-MS found m/z 859.3248 [M -H]-(calcd 859.3251 for C44H50O9F6Na).  R-mosher diester of 4-O-methylated-4\u2019: for partial NMR data see \u201cThe mosher analysis of cylindrocarpol\u201d and Figures S41 and S42; HR-ESI-MS found m/z 859.3249 [M -H]-(calcd 859.3251 for C44H50O9F6Na).   S10 Table S1. Primers used for fungal expression plasmids construction   Primer Sequence (5' to 3')SmaI-ascA-Fw TCGAGCTCGGTACCCATGGGTGCCACAACGAG SmaI-ascA-Rv CTACTACAGATCCCCTTATTTCCCTCGGTGAGCATTC ascA-Mid-Fw GCAAACAGGCTTCTGTTG ascA-Mid-Rv CAGAAGCCTGTTTGCCGAC pAdeA-SpeI-Fw TAGAGGATCTACTAGCGATATCATGGTGTTTTGATC pAdeA-SpeI-Rv AATCCATATGACTAGCTTTCCTATAATAGACTAGCGTG SmaI-ascB-Fw TCGAGCTCGGTACCCATGGGTTCTGCCATGG SmaI-ascB-Rv CTACTACAGATCCCCCTACTTCTTCAGGTATCCAATC SmaI-ascC-Fw TCGAGCTCGGTACCCATGGCCCCCAAACGC SmaI-ascC-Rv CTACTACAGATCCCCCTATGCGAATAGTGCGGGAG pTA_Prm_Fw1 GCTCGCGAGCGCGTTCCACTGCATCATCAGTCTAG pTA_Tmn_Rv1 AACGCGCTCGCGAGCAAGTACCATACAGTACCGCG KpnI-ascE-Fw CTGAATTCGAGCTCGGTACCATGAGTTGCGAAATTCCTC KpnI-ascE-Rv ACTACAGATCCCCGGGTACCCTAAGAGAAAATCTCGCTGGC KpnI-ascF-Fw CTGAATTCGAGCTCGGTACCATGGCATTCAACGAC KpnI-ascF-Rv ACTACAGATCCCCGGGTACCTTAAAGCTCCTTTCCTTC pUSA-Prm-Fw1 GCTCGCGAGCGCGTTCGATATCATGGTGTTTTGATC pUSA-Tmn-Rv1 AACGCGCTCGCGAGCCTTTCCTATAATAGACTAGCGTG SmaI-ascG-Fw TCGAGCTCGGTACCCATGGATAACCTATCGTCACTCG SmaI-ascG-Rv CTACTACAGATCCCCTTACATCTTTCTACGCTTAAACTCAAG pPTRI-HIndIII-Fw TGATTACGCCAAGCTCGATATCATGGTGTTTTGATC pPTRI-HindIII-Rv GCAGGCATGCAAGCTCTTTCCTATAATAGACTAGCGTG KpnI-ascD-Fw CTGAATTCGAGCTCGGTACCATGGCTGCCCAAATTC KpnI-ascD-Rv ACTACAGATCCCCGGGTACCTTAAGCCGAGACGTCAAC ascF-M1-Fw GACGGCTCATTATAGCGCGGCGTCGTGGTGGATGGGC ascF-M1-Rv GCTATAATGAGCCGTCGCGC ascF-M2-Fw CATTATAGCTGGGCGTCGGCGGCGATGGGCAACGGC ascF-M2-Rv CGACGCCCAGCTATAATGAG ascF-M3-Fw GAACATCAGCTACGGAGCGGCTGCGTATACCTGGCCCGAG ascF-M3-Rv TCCGTAGCTGATGTTCAGGC ascF-M4-Fw GCCGGCAATCTTCCTTGCGGGAATCACCACCGTC ascF-M4-Rv AAGGAAGATTGCCGGCTC S11 Table S2. Plasmids constructed for fungal transformation and their PCR conditions   Table S3. A. oryzae transformants constructed in this study   plasmid vector insert primer 1primer 2PCR templateascA-F SmaI-ascA-Fw ascA-Mid-Rv ascA-R ascA-Mid-Fw SmaI-ascA-Rv Prm-ascA-F pAdeA-SpeI-Fw ascA-Mid-Rv ascA-R-Tmn ascA-Mid-Fw pAdeA-SpeI-Rv pUNA-ascB pUNA digested with SmaIascB SmaI-ascB-Fw SmaI-ascB-Rv cDNA pTAex3-ascC pTAex3 digested with SmaIascC SmaI-ascC-Fw SmaI-ascC-Rv gDNA ascB+Tmn SmaI-ascB-Fw pTA_Tmn_Rv1 pUNA-ascB Prm+ascC pTA_Prm_Fw1 SmaI-ascC-Rv pTAex3-ascC pUSA-ascE pUSA digested with KpnIascE KpnI-ascE-Fw KpnI-ascE-Rv gDNA pUSA-ascF pUSA digested with KpnIascF KpnI-ascF-Fw KpnI-ascF-Rv gDNA ascF+Tmn KpnI-ascE-Fw pUSA-Tmn-Rv1 pUSA-ascE Prm+ascE pUSA-Prm-Fw1 KpnI-ascF-Rv pUSA-ascF pUNA-ascG pUNA digested with SmaIascG SmaI-ascG-Fw SmaI-ascG-Rv gDNA pPTRI-ascG pPTRI digested with HindIIIPrm-ascG-Tmn pPTRI-HIndIII-Fw pPTRI-HindIII-Rv pUNA-ascG pUSA-ascD pUSA digested with KpnIascD KpnI-ascD-Fw KpnI-ascD-Rv cDNA pBARI-ascD pBARI digested with HindIIIPrm-ascD-Tmn pPTRI-HIndIII-Fw pPTRI-HindIII-Rv pUSA-ascD ascF(mutant1)-F KpnI-ascF-Fw ascF-M1-Fw ascF(mutant1)-R+ascE ascF-M1-Rv KpnI-ascE-Rv ascF(mutant2)-F KpnI-ascF-Fw ascF-M2-Fw ascF(mutant2)-R+ascE ascF-M2-Rv KpnI-ascE-Rv ascF(mutant3)-F KpnI-ascF-Fw ascF-M3-Fw ascF(mutant3)-R+ascE ascF-M3-Rv KpnI-ascE-Rv ascF(mutant4)-F KpnI-ascF-Fw ascF-M4-Fw ascF(mutant4)-R+ascE ascF-M4-Rv KpnI-ascE-Rv pUNA-ascA pUNA digested with SmaIgDNA pUNA-ascApAdeA digested with SpeIpAdeA-ascAPTAex3-ascB+ascC pTAex3 digested with SmaIpUSA-ascF+ascE pUSA digested with KpnIpUSA-ascF(mutant1)+ascE pUSA digested with KpnIpUSA-ascF+ascE pUSA-ascF(mutant2)+ascE pUSA digested with KpnIpUSA-ascF+ascE pUSA-ascF(mutant3)+ascE pUSA digested with KpnIpUSA-ascF+ascE pUSA-ascF(mutant4)+ascE pUSA digested with KpnIpUSA-ascF+ascE Strain constructed Host strainPlasmid used in transformationA . oryzae/ascA A . oryzae NSAR1pAdeA-ascA A . oryzae/ascABC A . oryzae/ascA pTAex3-ascB+ascC A . oryzae/ascABCEF A . oryzae/ascABC pUSA-ascF+ascE A . oryzae/ascABCEFG A . oryzae/ascABCEF pPTRI-ascG A . oryzae/ascABCEFD A . oryzae/ascABCEF pBARI-ascD A . oryzae/ascABCEF(W127A) A . oryzae/ascABC pUSA-ascF(mutant1)+ascE A . oryzae/ascABCEF(W130A, W131A)A . oryzae/ascABC pUSA-ascF(mutant2)+ascE A . oryzae/ascABCEF(W207A, W209A)A . oryzae/ascABC pUSA-ascF(mutant3)+ascE A . oryzae/ascABCEF(W228A) A . oryzae/ascABC pUSA-ascF(mutant4)+ascE S12 Table S4. Primers used for cloning and mutagenesis study   Table S5. Plasmids constructed for in vitro assay    S13 Table S6. NMR data of the isolated compounds   1H NMR: 500 MHz, 13C NMR: 125 MHz (in CDCl3)  S14   1H NMR: 500 MHz, 13C NMR: 125 MHz (in CDCl3)  S15   1H NMR: 500 MHz, 13C NMR: 125 MHz (in CDCl3)  S16   Figure S1. Schematic representation and annotation of ascA-G Genes Amino acids (base pairs)Protein homologue, origin organismIdentities / SimilaritiesPredicted FunctionascA 2118 (6527)StbA, Stachybotrys bisbyi60% / 76%Polyketide synthase (PKS)ascB 1064 (3316)StbB, Stachybotrys bisbyi61% / 76%NRPS-like carboxylate reductaseascC 333 (1002)StbC, Stachybotrys bisbyi57% / 69%UbiA prenyltransferase (PT)ascD 560 (1995)AclH, Aspergillus oryzae RIB4057% / 72%Flavin-dependent halogenase (HLG)ascE 1069 (3535)AoCYP505A3, Aspergillus oryzae RIB4047% / 64%Cytochrome P450 / Cytochrome P450 reductase (P450/CPR)ascF 267 (894)AndB, Emericella variecolor30% / 49%Terpene cyclase (CYC)ascG 533 (1755)AtaF, Aspergillus terreus NIH262433% / 51%Cytochrome P450 S17 Figure S2. Sequence alignment between AscF, Pyr4, Trt1, AusL, AdrI, and AndB Red flames indicate the amino acids mutated into alanine in this work, black flames indicate catalytic acid and base residues identified in Pyr4 study (T. Itoh, K. Tokunaga, Y. Matsuda, I. Fujii, I. Abe, Y. Ebizuka, T. Kushiro, Nat. Chem., 2010, 2, 858\u2013864). Red and blue markers are transmembrane region predicted by TMHMM server.  AscF    1 MAFNDVPPPHVSPLYQ---PVYEATFGFAGLAWTLCYILYAREGLRTKSYGMPLFALANNFAWEMTYALYPyr4    1 MD-GWSDLSSAPPQYREVAGIADWALLAQGLGWSINYLAMIYHSYKDRTYGMAILPLCCNFAWEFVYSVITrt1    1 -------MPSIISDPQ---AYDIMLRLLQFSCWSLSYINTVRTTLSDQLPSVSFMSICCDVAWEFVYAFVAusL    1 MS--QLTISKIIEEPFSALSLSEMLKILAALGWSTNYLAMVYRTQADKLPAIAVLPLCCDIAWEFTYAWIAdrI    1 ME-KSTLLSAVLKHRDALASVAEFLRILAGICWTLNYFSMLRTSQKDKIPSTGIFPLCNDIGWEFIYAFIAndB    1 ----MQPITQIPLTFDT---VVNLLGSASGIGWILNYILMTYYSFRDKTYSMSMLPLCCNIAWEFVYGILAscF   68 V-ADAAREKTAMVIWMLIDIPIVYSLLRHGRNEWSHAPMVSR--NLGKIFVLLVALCATAHYSWASWWMGPyr4   70 YPSHNSAERAVLTTWMILNLFVMYTAIKFAPNEWQHAPLVRQ--CLPWIFPVAIAAFTAGHLALA-----Trt1   61 YPIASSHWAGGIRIWFAMHCVMLFIVAKYAPNDWDHVPLMKRF--ARLAYVAITIGFMAGHLALA-----AusL   69 YPQASGHWQGVVRVWFFLHTAVLAATLRYAPNDWAGTPLGESRGRLVLLYAAVIAAFAAGQLCLA-----AdrI   70 YPKASAHWEGGVRVWFLVHCIVIFFIIKNAHNEWDYFPLIQ--RNLYFLYGIVTIGFAIGQYSFA-----AndB   64 CPSSTFVVRPVILSWLVLNCLVVYAAIKYSPNEWAHAPLVQR--HLPLLFTVGIAACTGFHIALI-----AscF  135 NGIAMKSGKSYRGVEGLDPTEMAFWAVSVCQVVVSTSSLAQLITRQHTGGVSWAVWA--LRFLGTFIGLNPyr4  133 --------------ATVGVSKAANWGAFLCFELLTSGAVCQLMSRGSSRGASYTIWL--SRFLGSYIGGITrt1  124 --------------SEIGPALGFFWSGALCQITASLGSLCLLVCRGSTRGASIKTWNSYFRIIATVGGFTAusL  134 --------------LEMGGALGFHWGGALCQFLSSSAAVGQLLTRGHTRGASLLIWG--ARAISTAGGFVAdrI  133 --------------REVGPDLGFFYGGVLCQTLASLGPIAQILSRNSTRGASLLTWL--LRAVATFGGFIAndB  127 --------------RKFDPATAFLWSARSCQVLLSIGGLFQLLCRSSTKGGSYVLWL--SRFLGSICGVLAscF  203 ISYGWAWYTWPEAHAYFMSEPAIFLWGITTVCDIVYAIVFAKVRRNERVLEDGRKMAPRHEGKELPyr4  187 -FLHVRETHWPQEFGWISHPFVTWHGLMCFSLDIAYVTFLWRIRRQEHRSQRKKAL---------Trt1  180 -KMSIRHIWHLADEPWFDSPLCWFYIAITLTLDAIYPVFFFYFRAIEHPKKDSERKVE-------AusL  188 -KLCIRFQHQVDGAPWLDSPMCWFYIGIVLSLDASYPVLYQLTRRHEEASGGGKSGKVKNW----AdrI  187 -KLTIYYLTGNAAGPWFESPMCKFYIGLTLILDFTYPICYYVIRRQELVNDEGDKKKKTKSGKAAAndB  181 -KMTLMWKYGESRFPWLDDPLTAYCIALWIISDVLYGVVFYSLRSKELAGAGKAKAI--------\u2248\u00e7 W131,132 W207,209 W228 W128 S18    S19      Figure S3. Comparison between AscE and P450 BM-3 Alignment between AscE and P450 BM-3 (A), homology model of P450 domain (B) and flavin-NADP+ binding domain (C), and the reaction of P450 BM-3 (D) Heme, FAD, NADP+, and FMN binding sites of P450BM-38,9 were shown in the alignment. Homology model was built by Phyre2 server (http://www.sbg.bio.ic.ac.uk/phyre2/). The model of AscE P450 domain (1-462) (brown) was built by using the PDB model 4H23 (cyan) as a template, and that of flavin-NADP+ binding domain (504-1069) (brown) was built by using 1J9Z (cyan) as a template.  heme B) FAD FMN NADPH C) OH O(OH) (OH) (OH) OH O NADPH O2, H+NADP+ H2O 54% 20% 25% NADPH O2, H+NADP+ H2O O D) S20   Figure S4. MS spectra of the compounds in this study  S21  Figure S5. UV spectra of the compounds isolated in this study S22  Figure S6. SDS-PAGE analysis of the recombinant AscE and AscD From Rosetta2/pColdII-AscE (Lane2 & 4; insoluble & soluble fraction), negative control Rosetta2/pColdII (Lane1 & 3; insoluble & soluble fraction), Rosetta2/pET28a-AscD (Lane6; soluble fraction), and negative control Rosetta2/pET28a (Lane5; soluble fraction). Molecular weight of AscE is 120 kDa, and that of AscD is 63 kDa. M; Thermo Scientific PageRuler Prestained Protein Ladder (170, 130, 70 (purple), 55, 40, 35 kDa)     Figure S7. Absorption spectra of the recombinant AscE Soluble fraction of Rosetta2/pColdII-AscE (B), and negative control Rosetta2/pColdII (A).  1 2 3 4M [nm] [A u] [A u] [nm] Blue: +CORed:+CO, Na2S2O4Blue: +CORed:+CO, Na2S2O4A) B) S23  Figure S8. 4 was hydrolyzed to 4\u2019 in SN2 manner.  Figure S9. HPLC profile of in vitro assay of AscE by using 5-farnesyl-6-hydroxymellein as a substrate. Lane i shows a negative control, and lane ii shows complete reaction. The substrate (m/z = 397 [M-H]-) was converted into the product (m/z = 413 [M-H]-). The chromatograms were monitored at 295 nm.  (S) CHO OH HO O (R) CHO OH HO 4 cylindrocarpol (4\u2019)HO OH OH-H+ SN2 reaction12.5 15 17.5 20 22.5 [min] OH OH O O +16 i) ii) S24  Figure S10. HPLC analysis of the AscF mutants in vitro assay. Percentage showed the consumption of substrate. UV absorbance was 295 nm. S25  Figure S11. Phylogenetic tree analysis of meroterpenoid terpene cyclases Multiple sequence alignment, performed with ClustalW. The scale represents 0.10 amino acid substitutions per site. XiaH from Streptomyces sp. SCSIO 02999 was employed as out group. Accession numbers: AndB from Emericella variecolor, AtmB Aspergillus flavus, AusL Aspergillus nidulans FGSC A4, LtmB Epichloe festucae var. lolii, MacJ Penicillium terrestris, AdrI Penicillium chrysogenum, PaxM Penicillium paxilli, LtmB Epichloe festucae var. lolii, MacJ Penicillium terrestris, OclD Penicillium oxalicum 114-2, PaxB Penicillium paxilli, PrhH Penicillium brasilianum NBRC6234, Pyr4 Aspergillus fumigatus F37, Trt1 Aspergillus terreus, AscF Fusarium sp., Verruculide_cyclase Penicillium verruculosum, AFO69287 Periglandula ipomoeae, AFO69298 Epichloe O OH CO2CH3 O O OH O OH O O O O O O H O OH O R HO CHO OH O O NO OH O HN O HN O A G N 7 3 0 0 3 A G N 7 3 0 0 5 A G N 7 3 0 0 6 A G N 7 3 0 8 6 A G N 7 3 0 0 7 A F P 2 7 2 7 0 A G N 7 3 0 0 4 A G N 73 07 6 A G N 73 06 2 A B F 20 22 6 Lt m B A FO 69 29 8 A FO 69 28 7 AF O 69 30 5 AF P2 72 92 AF O 85 42 1 OA A3 29 41 KH N9 40 01 OA A3 48 64 XP _0 07 81 32 80 XP _0 07 81 62 70 XP _01 457 371 0 KF G8 037 6 XP_ 014 541 493 KID 816 91 KJK7 4552 KFH4 4079 AGN73 002 KJZ73006 KJZ71105 KOM21072 KOS19956 BAM84047 ODA80718KYK60562 BAU61559AGZ20190GAD99481 CAK48315 XP_001394250 GAA83986KKK13519 KKK13733 CDM28239 CRL19196 KO S38981 PaxB E3U BL6 O C K 81419 A G Z20474 X P _001826324 X P _002378013 E IT 78655 A tm B A 9 JP E 3 X P _ 0 1 5 4 0 6 2 3 2 V e rru cu lid e _ cycla se G A O 8 9 4 6 5 K JZ 8 0 3 3 8 P yr4 X P _ 7 5 1 2 7 0 K E Y 8 4 1 4 8 G A Q 0 3 6 8 2 X P _ 0 0 1 2 6 2 3 0 9 A n d B A 0 A 0 9 7 Z P D 8 P rh H C E J6 13 16 A us L C E L1 12 71T rt 1 A dr I C D M 27 37 7 X P _0 16 59 50 32 KU L8 18 46 CR L2 85 07 KO M 20 73 2 OB R0 97 84CE F7 96 29 XP _0 11 32 09 86 EY B2 79 98 XP _0 09 26 22 29KIL 841 21 EKG 137 29EXU 956 82KFG 8192 0 XP_0 07814 548XP_00 782368 6CEL0890 0 GAQ05405 GAO85985 EDP47980 GAO85956 GAQ05411 AscF GAQ34046 GAA83664 XP_001389192 EHA26643 MacJ Pc16g00320 XP_746967 KMK56825 KEY82996 XP_001261883 O clD XiaH KIA75414 X P _681413 G A O 83049 G A Q 09941 X P _001259220 E D P 52188 X P _753197 K E Y 81846 0.10 O OH O R S26 gansuensis, AFO69305 Aciculosporium take, AFO85421 Claviceps paspali, AFP27270 Epichloe festucae, AFP27292 Claviceps purpurea, AGN73002 Epichloe aotearoae, AGN73003 Epichloe occultans, AGN73004 Epichloe siegelii, AGN73005 Neotyphodium sp. FaTG-3, AGN73006 Neotyphodium sp. FaTG-2, AGN73007 Neotyphodium sp. FaTG-2, AGN73062 Epichloe funkii, AGN73076 Epichloe coenophiala, AGN73086 Neotyphodium sp. FaTG-4, AGZ20190 Penicillium crustosum, AGZ20474 Penicillium janthinellum, ABF20226 Epichloe festucae var. lolii, BAM84047 Tolypocladium album, BAU61559 Penicillium simplicissimum, CAK48315 Aspergillus niger, CDM27377 Penicillium roqueforti FM164, CDM28239 Penicillium roqueforti FM164, CEF79629 Fusarium graminearum, CEJ61316 Penicillium brasilianum, CEL08900 Aspergillus calidoustus, CEL11271 Aspergillus calidoustus, CRL19196 Penicillium camemberti, CRL28507 Penicillium camemberti, EDP47980 Aspergillus fumigatus A1163, EDP52188 Aspergillus fumigatus A1163, EHA26643 Aspergillus niger ATCC 1015, EIT78655 Aspergillus oryzae 3.042, EKG13729 Macrophomina phaseolina MS6, EXU95682 Metarhizium robertsii, EYB27998 Fusarium graminearum, GAA83664 Aspergillus kawachii IFO 4308, GAA83986 Aspergillus kawachii IFO 4308, GAD99481 Byssochlamys spectabilis No. 5, GAO83049 Aspergillus udagawae, GAO85956 Aspergillus udagawae, GAO85985 Aspergillus udagawae, GAO89465 Aspergillus udagawae, GAQ03682 Aspergillus lentulus, GAQ05405 Aspergillus lentulus, GAQ05411 Aspergillus lentulus, GAQ09941 Aspergillus lentulus, GAQ34046 Aspergillus niger, KEY81846 Aspergillus fumigatus var. RP-2014, KEY82996 Aspergillus fumigatus var. RP-2014, KEY84148 Aspergillus fumigatus var. RP-2014, KFG80376 Metarhizium anisopliae, KFG81920 Metarhizium anisopliae, KFH44079 Acremonium chrysogenum ATCC 11550, KHN94001 Metarhizium album ARSEF 1941, KIA75414 Aspergillus ustus, KID81691 Metarhizium guizhouense ARSEF 977, KIL84121 Fusarium avenaceum, KJK74552 Metarhizium anisopliae BRIP 53293, KJZ71105 Hirsutella minnesotensis 3608, KJZ73006 Hirsutella minnesotensis 3608, KJZ80338 Hirsutella minnesotensis 3608, KKK13519 Aspergillus rambellii, KKK13733 Aspergillus ochraceoroseus, KMK56825 Aspergillus fumigatus Z5, KOM20732 Ophiocordyceps unilateralis, KOM21072 Ophiocordyceps unilateralis, KOS19956 Escovopsis weberi, KOS38981 Penicillium nordicum, KUL81846 Talaromyces verruculosus, KYK60562 Drechmeria coniospora, B6H6U3 Penicillium chrysogenum ATCC 28089, OAA32941 Aschersonia aleyrodis RCEF 2490, OAA34864 Metarhizium rileyi RCEF 4871, OBR09784 Colletotrichum higginsianum IMI 349063, OCK81419 Lepidopterella palustris CBS 459.81, ODA80718 Drechmeria coniospora, XP_681413 Aspergillus nidulans FGSC A4, XP_746967 Aspergillus fumigatus Af293, XP_751270 Aspergillus fumigatus Af293, XP_753197  Aspergillus fumigatus Af293, XP_001259220 Aspergillus fischeri NRRL 181, XP_001261883 Aspergillus fischeri NRRL 181, XP_001262309 Aspergillus fischeri NRRL 181, XP_001389192 Aspergillus niger CBS 513.88, XP_001394250 Aspergillus niger CBS 513.88, XP_001826324 Aspergillus oryzae RIB40, XP_002378013 Aspergillus flavus NRRL3357, XP_007813280 Metarhizium acridum CQMa 102, XP_007814548 Metarhizium acridum CQMa 102, XP_007816270 Metarhizium robertsii ARSEF 23, XP_007823686 Metarhizium robertsii ARSEF 23, XP_009262229 Fusarium pseudograminearum CS3096, XP_011320986 Fusarium graminearum PH-1, XP_014541493 Metarhizium brunneum ARSEF 3297, XP_014573710 Metarhizium majus ARSEF 297, XP_015406232 Aspergillus nomius NRRL 13137, XP_016595032 Penicillium expansum S27  Figure S12. HPLC analysis of the product accumulated in A. oryzae/AscABCE i), A. oryzae/AscABCEF ii), W127A iii), W130A/W131A iv), W207A/W209A v), W228A vi). UV absorbance was 295 nm. The compound labeled as * is an unidentified compound which has UVmax at 272 and 282 nm. S28  Figure S13. HPLC analysis of the products accumulated in A. oryzae/AscABCEF i), AscABCDEF incubated with KCl ii), incubated with KBr iii). UV absorbance was 295 nm.  Figure S14. HPLC analysis of the products accumulated in Fusarium sp. incubated without any halogen source i) with KCl ii), with KBr iii). UV absorbance was 295 nm. S29  Figure S15. HPLC profile of AscD in vitro assay. 2 was incubated with soluble protein extract from Rosetta2/pET28a-AscD i), and the extract from Rosetta2/pET28 ii), and 5 was incubated with soluble protein extract from Rosetta2/pET28a-AscD iii), and the extract from Rosetta2/pET28 iv). The chromatograms were monitored at 295 nm.    Figure S16. The biosynthetic pathway of ascofuranone (A) and putative pathway of siccanochromenic acid (B)   OH O COOHOH HO COOH H H+ OH HO COOH OH HO CHOO O Cl OH HO CHOO HO Cl H+ OH HO CHOHO O OH HO CHO O OH OH HO CHO O ascofuranol ascofuranone siccanochromenic acidA) B) Cl Cl Cl S30  Figure S17. Comparison of terpene cyclization between ascochlorin and stachybotrydial  HO HO CHO O H+ HO HO CHO HO H HO CHO CHO O HO stachybotrydial A) B) OH HO O CHO HO HO CHO HO HO HO CHO O H+ OH HO CHOO Cl Cl Cl S31  Figure S18. 1H NMR spectrum of ascochlorin (1a)  Figure S19. 13C NMR spectrum of ascochlorin (1a)   OH HO CHOO Cl  OH HO CHOO Cl S32  Figure S20. 1H NMR spectrum of 3-bromoascochlorin (1b)  Figure S21. 13C NMR spectrum of 3-bromoascochlorin (1b)   OH HO CHOO Br  OH HO CHOO Br S33  Figure S22. 1H NMR spectrum of dechloroascochlorin (6)  Figure S23. 13C NMR spectrum of dechloroascochlorin (6)   OH HO CHOO  OH HO CHOO S34  Figure S24. 1H NMR spectrum of 12,13-dihydroascochlorin (7a)  Figure S25. 13C NMR spectrum of 12,13-dihydroascochlorin (7a)   OH HO CHOO Cl  OH HO CHOO Cl S35  Figure S26. 1H NMR spectrum of 3-bromo-12,13-dihydroascochlorin (7b)  Figure S27. 13C NMR spectrum of 3-bromo-12,13-dihydroascochlorin (7b)   OH HO CHOO Br  OH HO CHOO Br S36  Figure S28. 1H NMR spectrum of dechloro-12,13-dihydroascochlorin (5)  Figure S29. 13C NMR spectrum of dechloro-12,13-dihydroascochlorin (5)   OH HO CHOO  OH HO CHOO S37  Figure S30. 1H NMR spectrum of LL-Z1272\u03b2 (2)  Figure S31. 13C NMR spectrum of LL-Z1272\u03b2 (2)  0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.013.5 f1 (ppm)6 .2 0 3 .1 8 3 .1 4 8 .6 7 3 .1 2 2 .0 9 2 .0 9 1 .0 5 1 .0 2 0 .9 9 1 .0 0 1 .5 9 1 .5 9 1 .6 7 1 .6 7 1 .8 2 1 .9 4 1 .9 6 1 .9 7 2 .0 2 2 .0 3 2 .0 4 2 .0 6 2 .0 7 2 .0 9 2 .1 1 2 .1 2 2 .1 4 2 .4 7 3 .3 9 3 .4 0 5 .0 6 5 .0 7 5 .0 8 5 .0 8 5 .0 9 5 .0 9 5 .2 6 5 .2 6 5 .2 7 5 .2 7 5 .2 9 5 .2 9 6 .2 2 1 0 .0 2 1 2 .6 8 0102030405060708090100110120130140150160170180190200 f1 (ppm)1 6 .0 8 1 6 .2 7 1 7 .7 2 1 8 .0 2 2 1 .2 3 2 5 .7 4 2 6 .3 7 2 6 .7 2 3 9 .7 1 3 9 .7 6 1 1 0 .9 6 1 1 2 .1 9 1 1 3 .1 8 1 2 1 .1 6 1 2 3 .7 2 1 2 4 .4 7 1 3 1 .2 9 1 3 5 .5 3 1 3 8 .7 4 1 4 2 .1 2 1 6 2 .8 8 1 6 3 .8 9 1 9 3 .0 4  OH HO CHO  OH HO CHO S38  Figure S32. 1H NMR spectrum of cylindrocarpol (4\u2019)  Figure S33. 13C NMR spectrum of cylindrocarpol (4\u2019)   OH HO CHOHO OH  OH HO CHOHO OH S39  Figure S34. 1H NMR spectrum of 4-O-methylated-4\u2019  Figure S35. COSY spectrum of 4-O-methylated-4\u2019   OH O CHOHO OH S40  Figure S36. HMQC spectrum of 4-O-methylated-4\u2019  Figure S37. HMBC spectrum of 4-O-methylated-4\u2019  S41  Figure S38. Key HMBC correlation of 4-O-methylated-4\u2019  S42  Figure S39. 1H NMR spectra of S-mosher diester of 4-O-methylated-4\u2019  Figure S40. COSY spectrum of S-mosher diester of 4-O-methylated-4\u2019  5 4 3 2 1 6 8 OO 7 H 9 10 O 11 12 13 14 15 16 17 18 (R) 1920 232221 O HO (S) O S-mosher CF3 OCH3 (S) OH3CO F3C S43  Figure S41. 1H NMR spectrum of R-mosher diester of 4-O-methylated-4\u2019   Figure S42. COSY spectrum of R-mosher diester of 4-O-methylated-4\u2019   5 4 3 2 1 6 8 OO 7 H 9 10 O 11 12 13 14 15 16 17 18 (R) 1920 232221 O HO (R) O R-mosher OCH3 CF3 (R) OF3C H3CO S44 Supplementary References 1. Chooi, Y.-H.; Cacho, R.; Tang, Y., Identification of the viridicatumtoxin and griseofulvin gene clusters from Penicillium aethiopicum. Chemistry & biology 2010, 17, 483-494. 2. Jin, F. J.; Maruyama, J.-i.; Juvvadi, P. R.; Arioka, M.; Kitamoto, K., Development of a novel quadruple auxotrophic host transformation system by argB gene disruption using adeA gene and exploiting adenine auxotrophy in Aspergillus oryzae. FEMS microbiology letters 2004, 239, 79-85. 3. Kubodera, T.; Yamashita, N.; Nishimura, A., Transformation of Aspergillus sp. and Trichoderma reesei using the pyrithiamine resistance gene (ptrA) of Aspergillus oryzae. Bioscience, biotechnology, and biochemistry 2002, 66, 404-406. 4. Matsuda, Y.; Wakimoto, T.; Mori, T.; Awakawa, T.; Abe, I., Complete biosynthetic pathway of anditomin: nature\u2019s sophisticated synthetic route to a complex fungal meroterpenoid. Journal of the American Chemical Society 2014, 136, 15326-15336. 5. Gomi, K.; Iimura, Y.; Hara, S., Integrative transformation of Aspergillus oryzae with a plasmid containing the Aspergillus nidulans argB gene. Agricultural and biological chemistry 1987, 51, 2549-2555. 6. Arkoudis, E.; Stratakis, M., Synthesis of cordiaquinones B, C, J, and K on the basis of a bioinspired approach and the revision of the relative stereochemistry of cordiaquinone C. The Journal of organic chemistry 2008, 73, 4484-4490. 7. Zhang, X.; Archelas, A.; Furstoss, R., Microbial transformationsd. 19. Asymmetric dihydroxylation of the remote double bond of geraniol: a unique stereochemical control allowing easy access to both enantiomers of geraniol-6, 7-diol. The Journal of Organic Chemistry 1991, 56, 3814-3817. 8. Oulos, T. H. L. P. Structure of a Cytochrome P450 \u2013 Redox Partner Electron-Transfer Complex. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 1863\u20131868. 9. Joyce, M. G.; Ekanem, I. S.; Roitel, O.; Dunford, A. J.; Neeli, R.; Girvan, H. M.; Baker, G. J.; Curtis, R. A.; Munro, A. W.; Leys, D. The Crystal Structure of the FAD/NADPH-Binding Domain of Flavocytochrome P450 BM3. FEBS J. 2012, 279, 1694\u20131706.   ",
    "content": [
        "S1",
        "Supporting Information for",
        "",
        "A multidomain P450 epoxidase and a terpene cyclase from ascochlorin",
        "biosynthetic pathway in Fusarium sp.",
        "",
        "Zhiyang Quan,\u2020,# Takayoshi Awakawa,*,\u2020,\t\u22a5,# Dongmei Wang,\u2020, \u2021,# Yue Hu,\u2021 and Ikuro Abe*,\u2020, \u22a5",
        "",
        "\u2020 Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan",
        "\u22a5 Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Yayoi 1-1-1,",
        "Bunkyo-ku, Tokyo 113-8657, Japan",
        "\u2021 School of Pharmaceutical Sciences, Sun Yat-sen University, No. 135, Xingang Xi Road, Guangzhou, 510275,",
        "P. R. China",
        "",
        "",
        "Table of Contents",
        "Supplementary Material and Methods S2-S9",
        "Supplementary Tables S1-S6 S10-S15",
        "Supplementary Figures S1-S42 S16-S42",
        "Supplementary References S43",
        "",
        "S2",
        "Supplementary Materials and Methods ",
        "General Solvents and chemicals were purchased from Wako Chemicals Ltd. (Tokyo, Japan) or Kanto Chemical Co., Inc. (Tokyo, Japan), unless noted otherwise. Oligonucleotide primers were purchased from Eurofins Genetics",
        "(Tokyo, Japan), and Sigma Aldrich Japan Genosys (Table S1). PCR was performed using a TaKaRa PCR Thermal Cycler Dice\u00ae Gradient (TaKaRa), with KOD FX Neo (TOYOBO) or iProof DNA polymerase (BIO-RAD). Ligations of DNA fragments were performed using an in-Fusion HD cloning kit (Clontech). Sequence",
        "analyses were performed by Eurofins Genetics (Tokyo). Total mRNA isolation of Fusarium sp. NBRC100844 was performed utilizing ISOGEN Reagent (NIPPON GENE CO., LTD.). Reverse transcription of mRNA was performed utilizing a SuperScript\u2122 III First-Strand Synthesis System (Thermo Fisher Scientific Inc.). Silica",
        "gel column chromatography was performed using Silica Gel 60 N (spherical, neutral, 40-50 \u03bcm) (Kanto Chemical Co., Inc.). Analytical and preparative HPLC were performed on a Shimadzu Prominence system, using a an ODS-80TM column (4.6 i.d. x 150 mm, Tosoh Co. Ltd.) and an ODS-80TM column (7.8 i.d. x 300 mm,",
        "Tosoh Co. Ltd.). Samples for LC-MS analysis were injected into an Shimadzu Prominence system HPLC-MicroTOF mass spectrometer (Bruker Daltonics), using electrospray ionization with a COSMOSIL 2.5C18-MS-II column (2.0 i.d. x 75 mm; Nacalai Tesque, Inc.). NMR spectra were obtained at 500 MHz (1H) and 125 MHz",
        "(13C) with a JEOL ECX-500 or ECZ-500 spectrometer, and chemical shifts were recorded with reference to solvent signals (1H NMR: CDCl3 7.26 ppm; 13C NMR: CDCl3 77.0 ppm).\tOptical rotation of each metabolite was measured utilizing DIP-1000 digital polarimeter (JASCO). The ascochlorin producing strain, Fusarium sp.",
        "NBRC100844 was purchased from NITE. Draft genome sequencing and assembling of Fusarium sp. NBRC100844 was ordered from Macrogen Japan (Kyoto, Japan). Gene prediction was performed by AUGUSTUS (http://bioinf.uni-greifswald.de/webaugustus/). The glufosinate solution for the fungal",
        "transformation was extracted from Basta (Bayer), as previously described,1 and used at a 50 \u00b5L/mL concentration. ",
        "Plasmids construction and fungal transformation Aspergillus oryzae NSAR1 (niaD-, sC-, \u0394argB, adeA-) and fungal transformation vector pTAex3, pUSA, pUNA, and pAdeA are kindly provided by Prof. K. Gomi (Graduate School of Agricultural Sciences, Tohoku",
        "University) and Prof. K. Kitamoto (Graduate School of Agricultural Sciences, The University of Tokyo).2 pPTRI vector was purchased from TAKARA.3 pBARI vector was constructed based on pPTRI as previously reported.4 Fungal transformation was performed by the protoplast\u2013polyethylene glycol method, as reported",
        "previously.5 1. Plasmids construction Primers for fungal expression plasmids construction used in this research were listed in Table S1. The",
        "S3",
        "procedures of plasmids construction were summarized in Table S2, and all the ligations are performed utilizing a in-Fusion HD cloning kit.",
        "2. Fungal transformation A. oryzae transformants constructed for this study and their construction procedures are summarized in Table S3.",
        "",
        "Constructions of plasmids for in vitro assay and mutagenesis study Primers for in vitro assay and mutagenesis study were listed in Table S4. Ligations of pET28a-AscD,",
        "pColdII-AscE, and pESC-URA-AscF were summarized in Table S5. Point mutation of AscF was performed using PCR method. The reaction solution of PCR was digested with DpnI (TAKARA) and purified to linear DNA. The linear DNA was introduced to DH5\u03b1 (Clontech) to yield plasmid for mutation. The information of mutation",
        "plasmid construction was summarized in Table S5.  Preparation of the protein lysate containing AscD from in E. coli",
        "E. coli RosettaII (DE3) pLysS cells harboring pET28a-AscD were cultured to an OD600 of 0.7 in LB media",
        "containing 50\u2009\u03bcg\u2009ml-1 kanamycin and 34 \u03bcg\u2009ml-1 chloramphenicol at 37\u2009\u00b0C. Isopropyl \u03b2-D-1-thiogalactopyranoside was then added to a final concentration of 0.4\u2009mM to induce gene expression, and the",
        "cultures were incubated further for 16\u2009h at 15\u2009\u00b0C. The 200 mL E. coli cells were harvested by centrifugation at 5,000\u2009g and resuspended in 4 mL buffer A [50\u2009mM Tris\u2013HCl buffer pH 7.5, containing 300\u2009mM NaCl, 1 mM EDTA, and 2 mM DTT]. The cells were disrupted by sonication and the lysate was centrifuged at 12,000\u2009g for",
        "15\u2009min. The soluble protein lysate was concentrated into 0.5 mL, and used for the assay immediately. ",
        "Preparation of the protein lysate containing AscE from in E. coli E. coli RosettaII (DE3) pLysS cells harboring pColdII-AscE were cultured to an OD600 of 0.5 in ZYM-5052 auto-inducing medium (F. W. Studier, Structural Genomics, Methods in Molecular Biology, Vol.1091, pp 17-32,",
        "(2013)) containing 50\u2009\u03bcg\u2009ml-1 kanamycin and 100 \u03bcg\u2009ml-1 ampicillin at 37\u2009\u00b0C. Isopropyl",
        "\u03b2-D-1-thiogalactopyranoside, aminolevlic acid, and Fe(SO4)2(NH4)2\uff656H2O was then added to a final concentration of 0.05\u2009mM, 225 \u03bcg/mL, and 300 \u03bcM to induce gene expression and biosynthesis of heme, and the cultures were incubated further for 16\u2009h at 15\u2009\u00b0C. The 50 mL E. coli cells were harvested by centrifugation at 5,000\u2009g and",
        "resuspended in 5 mL buffer B [50\u2009mM Tris\u2013HCl buffer pH 8.0, containing 200\u2009mM NaCl, 20% (v/v) glycerol, and Complete Ultra Tablets Mini EDTA-free (Roche)]. The cells were disrupted by sonication and the lysate",
        "was centrifuged at 12,000\u2009g for 15\u2009min. The reddish soluble protein lysate was concentrated into 2.0 mL, and used for the assay immediately. ",
        "Preparation of microsome fraction containing AscF from yeast",
        "S4",
        "pESC-URA-AscF was introduced into Saccharomyces cerevisiae INVSC1 (invitrogen) with Frozen-EZ Yeast transformation II (Zymo research). The transformant was inoculated into 10 mL Synthetic dextrose (SD)-Ura",
        "medium, and incubated at 30 \u00baC for 2 days as Preculture1. Preculture1 was transferred into 500 mL SD-Ura medium, and incubated at 30 \u00baC in 1 day as Preculture2. The cells in Preculture2 was centrifuged, resuspended with Synthetic Glactose (SG)-Ura medium, and transferred into 500 mL SG-Ura medium, and incubated at 30",
        "\u00baC for 1 day. Cells from 250 mL culture were harvested, resuspended in 10 mL of 0.1 M KPB (pH 7.4) and disrupted with glass beads. After centrifugation (10,000 g) to remove the cell debris, ultracentrifugation (100,000 g) was carried out fort 1 hour to collect the microsome fraction which was suspended in 500 \u03bcL of 0.1",
        "M KPB (pH 7.4) with 24 mM CHAPS. ",
        "Assay of AscD reaction For assay of AscD, 200 \u03bcM FAD+, 20 mM NADH, 200 \u03bcM 2 or 5 were incubated with the soluble protein lysate from AscD-expressing culture with total 50 \u03bcL scale for 30 \u00baC in 400 min, and the reaction was extracted with",
        "500 \u00b5L of EtoAc, and the extract was evaporated in vacuo. 50 \u03bcL of methanol was added into the extract, and 20 \u03bcL was analyzed with HPLC. ",
        "Assay of AscEF reaction CO spectra assay for AscE was performed as the literature. For assay of AscE, 200 \u03bcM FAD+, 10 mM NADPH, 200 \u03bcM 2 (or 5-farnesyl-6-hydroxymellein) were incubated with the soluble protein lysate from AscE-expressing culture with total 50 \u03bcL scale for 30 \u00baC in 12 hr, and 25 \u03bcL of the microsome fraction containing",
        "AscF was added into the reaction. After additional 12 hr incubation, enzymes in the assay were precipitated by addition of 50 \u03bcL methanol and centrifugation. 20 \u03bcL of the reaction was analyzed with HPLC.",
        "",
        "Synthesis and preperation of racemic 46 1. Preparation of bromohydrin-2 a) Synthesis of bromohydrin-2 from 2",
        "",
        "Compound 2 (3.5 mg, 10 \u03bcmol) was dissolved in THF (372 \u03bcL) and H2O (105 \u03bcL), then the solution",
        "was left on ice-water mixture while stiring until the temperature of the whole system fell to 0 \u00baC. Recrystallized N-bromosuccinimide (NBS, 0.6 mg, 3 \u03bcmol) was added to solution of 2, and stirred for 30 min at 30 \u00baC. This operation was repeated for 6 times. Then, the reaction mixture was subjected to a",
        "N Br",
        "O O",
        "N-bromosuccinimideCHO",
        "OH",
        "HO",
        "2",
        "THF, H2O, at 273",
        "KCHO OH",
        "HO",
        "HO",
        "Br",
        "bromohydrin-2",
        "S5",
        "semi-preparative HPLC at once to isolate bromohydrin-2 as clear oil. b) Isolation of bromohydrin-2",
        "The mixture was subjected to a reverse-phase preparative HPLC, with a solvent system of milliQ (solvent A) and acetonitrile (solvent B), at a flow rate of 3.5 mL/min and a column temperature at 40 \u00baC. Isolation was started with solvent B/solvent A (85:15), then a linear gradient from B/A (85:15) to",
        "B/A (100:0) within the following 5 min, B/A (100:0) for an additional 1min. Bromohydrin-2 was yielded as clear oil. 6 trials (compound 2 at a total weight of 21 mg, 60 \u03bcmol) was conducted at the same time in order to",
        "accumulate enough bromohydrin-2, the precursor of racemic 4. ",
        "2. Synthesis of racemic 4",
        "a) Dehydrochlorination of bromohydrin-2",
        "",
        "Bromohydrin-2 prepared in last step was added into a slurry of methanol (2 mL) and K2CO3 (50 mg,",
        "360 \u03bcmol), and stirred for 30 min at room temperature to yield racemic 4. b) Purification of racemic 4 The reaction slurry containing racemic 4 was evaporated to remove the methanol firstly, and the residue",
        "was extracted with ethyl acetate from water. The extract was subjected to a silica-gel column chromatography and eluted using hexane:ethyl acetate (1:9) to yield racemic 4 (1.7 mg, 4.6 \u03bcmol) as a clear oil.",
        "",
        "The mosher analysis of cylindrocarpol (4\u2019)7 1. Synthesis of 4-O-methylated-4\u2019",
        "",
        "A mixture of 4\u2019 (2.0 mg), MeI (20 \u03bcl), and K2CO3 (20 mg) in 2-butanone (0.3 ml) was stirred at room temperature for 15 h. The reaction mixture was diluted with EtOAc (5 ml) and washed with H2O (5 ml)",
        "twice, and the organic layer was collected and concentrated to afford the methylated derivative (2.0 mg, pale yellow oil). ",
        "OH",
        "HO",
        "CHOHO",
        "Br",
        "OH",
        "HO",
        "CHO",
        "O",
        "bromohydrin-2 racemic",
        "4K2CO3 methanol at room",
        "temperature5",
        "4 3 2 1 6",
        "9 10 11 12 13 14 15 16",
        "17 18 1920",
        "232221",
        "CHO 8 OH",
        "7 HO",
        "cylindrocarpol",
        "(4\u2019)HO",
        "OH",
        "CHO",
        "OH",
        "MeO",
        "HO",
        "OH",
        "4-O-methylated-4\u2019",
        "MeI,",
        "K2CO32-butanone at room",
        "S6",
        "1H NMR (partial assignment, 500 MHz, CDCl3) 12.4 (1H, s, 6-OH), 10.1 (1H, s, H-8), 6.28 (1H, s, H-3),",
        "5.17 (1H. m, H-10), 5.16 (1H, m, H-14), 3.89 (3H, s, 4-OMe), 3.34 (1H, m, H-18), 3.30 (2H, m, H-9), 2.56",
        "(3H, s, H-7), 2.09 (2H, m, H-16), 2.02 (2H, m, H-13), 1.96 (2H, m, H-12), 1.76 (3H, brs, H-23), 1.59 (3H, brs, H-22), 1.41, 1.58 (2H, m, H-17), 1.19 (3H, brs, H-20), 1.14 (3H, brs, H-21). ",
        "Synthesis of S-mosher diester of 4-O-methylated-4\u2019",
        "",
        "4-O-methylated-4\u2019 (1.0 mg) was dissolved in pyridine (0.3 ml, dehydrated) and treated with excess amount of (-)-(R)-MTPA-Cl (10\u03bcl) at room temperature for 1 h. The reaction mixture was diluted with EtOAc and washed with H2O and saturated NaHCO3. The organic layer was concentrated and purified by preparative",
        "HPLC (isocratic in 100% CH3CN) to afford a S-mosher diester of 4-O-methylated-4\u2019 (ca. 0.5 mg).  1H NMR (partial assignment, 500 MHz, CDCl3) 9.99 (1H, s, H-8), 6.64 (1H, s, H-3), 5.00 (1H, m, H-14),",
        "4.97 (1H, m, H-18), 4.95 (1H, m, H-10), 3.89 (3H, s, 4-OMe), 3.66 (3H, s, 4-Mosher-OMe or 6-Mosher-OMe), 3.56 (3H, s, 4-Mosher-OMe or 6-Mosher-OMe), 3.10 (2H, m, H-9), 2.63 (3H, s, H-7), 1.99 (2H, m, H-13), 1.91 (2H, m, H-12), 1.83 (2H, m, H-16), 1.62 (3H, s, H-23), 1.56, 1.66 (2H, m, H-17), 1.49 (3H, s,",
        "H-22), 1.20 (3H, brs, H-20), 1.14 (3H, brs, H-21).  2. Synthesis of R-mosher diester of 4-O-methylated-4\u2019",
        "",
        "In the same manner, 4-O-methylated-4\u2019 (1.0 mg) was treated with excess amount of (+)-(S)-MTPA-Cl (10",
        "CHO OH",
        "MeO",
        "HO",
        "OH",
        "4-O-methylated-4\u2019",
        "(-)-(R)-MTPA-Cl",
        "pyridine",
        "at room",
        "temperatureOO H",
        "O",
        "(R) O",
        "HO",
        "(S) O CF3",
        "OCH3",
        "(S)",
        "OH3CO",
        "F3C",
        "S-mosher diester of",
        "4-O-methylated-4\u2019CHO OH",
        "MeO",
        "HO",
        "OH",
        "4-O-methylated-4\u2019",
        "(-)-(S)-MTPA-Cl",
        "pyridine",
        "at room",
        "temperatureR-mosher diester of",
        "4-O-methylated-4\u2019OO H",
        "O",
        "(R) O",
        "HO",
        "(R) O OCH3",
        "CF3",
        "(R)",
        "OF3C",
        "H3CO",
        "S7",
        "\u03bcl) at room temperature for 1 h. The reaction mixture was diluted with EtOAc and washed with H2O and saturated NaHCO3. The organic layer was concentrated and subjected to NMR analysis without purification.",
        "1H NMR (partial assignment, 500 MHz, CDCl3) 9.99 (1H, s, H-8), 6.64 (1H, s, H-3), 5.04 (1H, m, H-14),",
        "4.96 (1H, m, H-18), 4.75 (1H, m, H-10), 3.88 (3H, s, 4-OMe), 3.66 (3H, s, 4-Mosher-OMe or",
        "6-Mosher-OMe), 3.57 (3H, s, 4-Mosher-OMe or 6-Mosher-OMe), 3.11 (2H, m, H-9), 2.63 (3H, s, H-7), 2.01 (2H, m, H-13), 1.93 (2H, m, H-16), 1.92 (2H, m, H-12), 1.63,1.71 (2H, m, H-17), 1.62 (3H, brs, H-23), 1.53 (3H, brs, H-22), 1.15 (3H, brs, H-20), 1.11 (3H, brs, H-21).",
        "",
        "Analytical conditions Metabolites from the Aspergillus oryzae transformants and Fusarium sp. NBRC100844 were analyzed by",
        "HPLC, with a solvent system of 0.1% formic acid (solvent A) and acetonitrile containing 0.1% formic acid (solvent B), at a flow rate of 1.0 ml/min and a column temperature of 40 \u00b0C. Separation was performed with solvent B/solvent A (50:50), a linear gradient from 50:50 to 80:20 within the following 15 min, a linear",
        "gradient from 80:20 to 100:0 within the following 5 min, 100:0 for 5 additional min. ",
        "Isolation of the metabolites from Fusarium sp. NBRC100844 Fusarium sp. was cultured at 30 \u00baC for 7 days in 2 L flasks containing 1 L DPY medium. After filtering, the mycelia were lyophilized to dryness. Dried mycelia were extracted by acetone. The extraction solution was concentrated in vacuo to remove the solvent. The extract (146 mg) was subjected to silica-gel column",
        "chromatography and eluted stepwise using a hexane:acetone gradient (100:0 to 70:30). Fractions containing 6, 5, 1a, and 7a were further purified by reverse-phase preparative HPLC equipped with an Ultimate AQ-C18 column (Welch Inc., Ellicott, MO, USA, 5 \u03bcm, 10 mm i.d. x 250 mm) using acetonitrile-water (70:30) as the",
        "eluting solvent (flow rate 3.0 mL/min) to yield 5 (2.1 mg), 6 (3.8 mg), 1a (24.9 mg) and 7a (10.1 mg). For, 1b and 7b, Fusarium sp. was cultured at 30oC for 7 days in two 2 L flasks containing 1 L CD-NaBr medium",
        "(NaNO3 0.3%, K2HPO4 0.1%, MgSO4\u30fb7H2O 0.05%, FeSO4\u30fb7H2O 0.002%, Glucose 2%, NaBr 0.35%, pH 5.5) for each flask. After filtering, the mycelia were lyophilized to dryness. Dried mycelia were extracted by acetone. The extraction solution was concentrated in vacuo to remove the solvent. The extract (720 mg) was subjected to silica-gel column chromatography and eluted stepwise using a hexane: acetone gradient (95:5 to 70:30).",
        "Fractions that contained 1b and 7b were further purified by reverse-phase preparative HPLC using acetonitrile-water (70:30) as the eluting solvent (flow rate 3.0 mL/min) to yield 1b (7.0 mg), 7b (35 mg). ",
        "Isolation of the metabolites accumulated in Aspergillus oryzae transformants  Isolation of AscABC product (2) from A. oryzae transformant",
        "S8",
        "The extract from 3 L culture of A. oryzae NSAR1 harboring ascABC was subjected to silica-gel column chromatography and eluted using chloroform:methanol (100:0). Fractions that contained 2 yield 21.0 mg of",
        "a clear oil.  Isolation of AscABCEF product (5) from A. oryzae transformant",
        "The extract from 1 L culture of A. oryzae NSAR1 harboring ascABCEF was subjected to silica-gel column chromatography and eluted stepwise using a chloroform:methanol gradient (100:0 to 90:10). Fractions that contained 5 were further purified by reverse-phase preparative HPLC (40% aqueous acetonitrile, 3.0 mL/min)",
        "to yield 5.2 mg of a clear oil.  Isolation of AscABCE product (4\u2019) from A. oryzae transformant",
        "The extract from 1 L culture of A. oryzae NSAR1 harboring ascABCE and ascF (W130A, W131A) was subjected to silica-gel column chromatography and eluted stepwise using a chloroform:methanol gradient (100:0 to 90:10). Fractions that contained 4\u2019 were further purified by reverse-phase preparative HPLC",
        "(30% aqueous acetonitrile, 3.5 mL/min) to yield 5.0 mg of a clear oil.",
        "Isolation of AscABCEFG product (6) from A. oryzae transformant",
        "The extract from 1 L culture of A. oryzae NSAR1 harboring ascABCEFG was subjected to silica-gel column chromatography and eluted stepwise using a chloroform:methanol gradient (100:0 to 90:10). Fractions that contained 6 were further purified by reverse-phase preparative HPLC (40% aqueous acetonitrile, 3.0 mL/min)",
        "to yield 0.1 mg of a white solid. ",
        "Summary of analytical data Ascochlorin (1a): White solid; for NMR data see Table S6 (S13) and Figures S18 and S19; HR-ESI-MS found m/z 403.1682 [M -H]-(calcd 403.1676 for C23H28O4Cl). The NMR data were in good agreement with the reported data.",
        "3-Bromoascochlorin (1b): White solid; for NMR data see Table S6 (S13) and Figures S20 and S21; HR-ESI-MS found m/z 447.1176 [M -H]-(calcd 447.1171 for C23H28O4Br). The NMR data were in good agreement with",
        "the reported data.  dechloroascochlorin (6): White solid; for NMR data see Table S6 (S13) and Figures S22 and S23; HR-ESI-MS",
        "found m/z 369.2071 [M -H]-(calcd 369.2066 for C23H29O4). The NMR data were in good agreement with the reported data. ",
        "S9",
        "12,13-dihydroascochlorin (7a): White solid; for NMR data see Table S6 (S14) and Figures S24 and S25; HR-ESI-MS found m/z 405.1838 [M -H]-(calcd 405.1833 for C23H30O4Cl). The NMR data were in good agreement",
        "with the reported data.  3-bromo-12,13-dihydroascochlorin (7b): White solid; for NMR data see Table S6 (S14) and Figures S26 and",
        "S27; HR-ESI-MS found m/z 449.1310 [M -H]-(calcd 449.1333 for C23H30O4Br). The NMR data were in good agreement with the reported data. ",
        "dechloro-12,13-dihydroascochlorin (5): White solid; for NMR data see Table S6 (S14) and Figures S28 and S29; HR-ESI-MS found m/z 371.2225 [M -H]-(calcd 371.2228 for C23H31O4). The NMR data were in good agreement with the reported data.",
        "LL-Z1272\u03b2 (2): Clear oil; for NMR data see Table S6 (S15) and Figures S30 and S31; HR-ESI-MS found m/z 355.2259 [M -H]-(calcd 355.2279 for C23H31O3). The NMR data were in good agreement with the reported data.",
        "cylindrocarpol (4\u2019): Clear oil; for NMR data see Table S6 (S15) and Figures S32 and S33; HR-ESI-MS found m/z 389.2307 [M -H]-(calcd 389.2333 for C23H33O5). The NMR data were in good agreement with the reported",
        "data. ",
        "4-O-methylated-4\u2019: pale yellow oil; for NMR data see \u201cThe mosher analysis of cylindrocarpol\u201d and Figures S34, S35, S36, S37 and S38; HR-ESI-MS found m/z 405.2625 [M + H]+ (calcd 405.2636 for C24H37O5). ",
        "S-mosher diester of 4-O-methylated-4\u2019: for partial NMR data see \u201cThe mosher analysis of cylindrocarpol\u201d and Figures S39 and S40; HR-ESI-MS found m/z 859.3248 [M -H]-(calcd 859.3251 for C44H50O9F6Na). ",
        "R-mosher diester of 4-O-methylated-4\u2019: for partial NMR data see \u201cThe mosher analysis of cylindrocarpol\u201d and Figures S41 and S42; HR-ESI-MS found m/z 859.3249 [M -H]-(calcd 859.3251 for C44H50O9F6Na).  ",
        "S10",
        "Table S1. Primers used for fungal expression plasmids construction",
        "",
        "Primer Sequence (5' to 3')SmaI-ascA-Fw TCGAGCTCGGTACCCATGGGTGCCACAACGAG SmaI-ascA-Rv CTACTACAGATCCCCTTATTTCCCTCGGTGAGCATTC ascA-Mid-Fw GCAAACAGGCTTCTGTTG ascA-Mid-Rv CAGAAGCCTGTTTGCCGAC pAdeA-SpeI-Fw TAGAGGATCTACTAGCGATATCATGGTGTTTTGATC pAdeA-SpeI-Rv AATCCATATGACTAGCTTTCCTATAATAGACTAGCGTG SmaI-ascB-Fw TCGAGCTCGGTACCCATGGGTTCTGCCATGG SmaI-ascB-Rv CTACTACAGATCCCCCTACTTCTTCAGGTATCCAATC SmaI-ascC-Fw TCGAGCTCGGTACCCATGGCCCCCAAACGC SmaI-ascC-Rv CTACTACAGATCCCCCTATGCGAATAGTGCGGGAG pTA_Prm_Fw1 GCTCGCGAGCGCGTTCCACTGCATCATCAGTCTAG pTA_Tmn_Rv1 AACGCGCTCGCGAGCAAGTACCATACAGTACCGCG KpnI-ascE-Fw CTGAATTCGAGCTCGGTACCATGAGTTGCGAAATTCCTC KpnI-ascE-Rv ACTACAGATCCCCGGGTACCCTAAGAGAAAATCTCGCTGGC KpnI-ascF-Fw CTGAATTCGAGCTCGGTACCATGGCATTCAACGAC KpnI-ascF-Rv ACTACAGATCCCCGGGTACCTTAAAGCTCCTTTCCTTC pUSA-Prm-Fw1 GCTCGCGAGCGCGTTCGATATCATGGTGTTTTGATC pUSA-Tmn-Rv1 AACGCGCTCGCGAGCCTTTCCTATAATAGACTAGCGTG SmaI-ascG-Fw TCGAGCTCGGTACCCATGGATAACCTATCGTCACTCG SmaI-ascG-Rv CTACTACAGATCCCCTTACATCTTTCTACGCTTAAACTCAAG pPTRI-HIndIII-Fw TGATTACGCCAAGCTCGATATCATGGTGTTTTGATC pPTRI-HindIII-Rv GCAGGCATGCAAGCTCTTTCCTATAATAGACTAGCGTG KpnI-ascD-Fw CTGAATTCGAGCTCGGTACCATGGCTGCCCAAATTC KpnI-ascD-Rv ACTACAGATCCCCGGGTACCTTAAGCCGAGACGTCAAC ascF-M1-Fw GACGGCTCATTATAGCGCGGCGTCGTGGTGGATGGGC ascF-M1-Rv GCTATAATGAGCCGTCGCGC ascF-M2-Fw CATTATAGCTGGGCGTCGGCGGCGATGGGCAACGGC ascF-M2-Rv CGACGCCCAGCTATAATGAG ascF-M3-Fw GAACATCAGCTACGGAGCGGCTGCGTATACCTGGCCCGAG ascF-M3-Rv TCCGTAGCTGATGTTCAGGC ascF-M4-Fw GCCGGCAATCTTCCTTGCGGGAATCACCACCGTC ascF-M4-Rv AAGGAAGATTGCCGGCTC",
        "S11",
        "Table S2. Plasmids constructed for fungal transformation and their PCR conditions",
        "",
        "",
        "Table S3. A. oryzae transformants constructed in this study",
        "",
        "",
        "plasmid vector insert primer 1primer 2PCR",
        "templateascA-F SmaI-ascA-Fw ascA-Mid-Rv ascA-R ascA-Mid-Fw SmaI-ascA-Rv Prm-ascA-F pAdeA-SpeI-Fw ascA-Mid-Rv ascA-R-Tmn ascA-Mid-Fw pAdeA-SpeI-Rv",
        "pUNA-ascB pUNA digested with SmaIascB SmaI-ascB-Fw SmaI-ascB-Rv cDNA pTAex3-ascC pTAex3 digested with SmaIascC SmaI-ascC-Fw SmaI-ascC-Rv gDNA",
        "ascB+Tmn SmaI-ascB-Fw pTA_Tmn_Rv1 pUNA-ascB Prm+ascC pTA_Prm_Fw1 SmaI-ascC-Rv pTAex3-ascC",
        "pUSA-ascE pUSA digested with KpnIascE KpnI-ascE-Fw KpnI-ascE-Rv gDNA pUSA-ascF pUSA digested with KpnIascF KpnI-ascF-Fw KpnI-ascF-Rv gDNA",
        "ascF+Tmn KpnI-ascE-Fw pUSA-Tmn-Rv1 pUSA-ascE Prm+ascE pUSA-Prm-Fw1 KpnI-ascF-Rv pUSA-ascF",
        "pUNA-ascG pUNA digested with SmaIascG SmaI-ascG-Fw SmaI-ascG-Rv gDNA pPTRI-ascG pPTRI digested with HindIIIPrm-ascG-Tmn pPTRI-HIndIII-Fw pPTRI-HindIII-Rv pUNA-ascG pUSA-ascD pUSA digested with KpnIascD KpnI-ascD-Fw KpnI-ascD-Rv cDNA pBARI-ascD pBARI digested with HindIIIPrm-ascD-Tmn pPTRI-HIndIII-Fw pPTRI-HindIII-Rv pUSA-ascD",
        "ascF(mutant1)-F KpnI-ascF-Fw ascF-M1-Fw ascF(mutant1)-R+ascE ascF-M1-Rv KpnI-ascE-Rv ascF(mutant2)-F KpnI-ascF-Fw ascF-M2-Fw ascF(mutant2)-R+ascE ascF-M2-Rv KpnI-ascE-Rv ascF(mutant3)-F KpnI-ascF-Fw ascF-M3-Fw ascF(mutant3)-R+ascE ascF-M3-Rv KpnI-ascE-Rv ascF(mutant4)-F KpnI-ascF-Fw ascF-M4-Fw ascF(mutant4)-R+ascE ascF-M4-Rv KpnI-ascE-Rv",
        "pUNA-ascA pUNA digested with SmaIgDNA",
        "pUNA-ascApAdeA digested with",
        "SpeIpAdeA-ascAPTAex3-ascB+ascC pTAex3 digested with",
        "SmaIpUSA-ascF+ascE pUSA digested with",
        "KpnIpUSA-ascF(mutant1)+ascE pUSA digested with KpnIpUSA-ascF+ascE pUSA-ascF(mutant2)+ascE pUSA digested with KpnIpUSA-ascF+ascE pUSA-ascF(mutant3)+ascE pUSA digested with KpnIpUSA-ascF+ascE pUSA-ascF(mutant4)+ascE pUSA digested with KpnIpUSA-ascF+ascE",
        "Strain constructed Host strainPlasmid used in transformationA . oryzae/ascA A . oryzae NSAR1pAdeA-ascA A . oryzae/ascABC A . oryzae/ascA pTAex3-ascB+ascC A . oryzae/ascABCEF A . oryzae/ascABC pUSA-ascF+ascE A . oryzae/ascABCEFG A . oryzae/ascABCEF pPTRI-ascG A . oryzae/ascABCEFD A . oryzae/ascABCEF pBARI-ascD A . oryzae/ascABCEF(W127A) A . oryzae/ascABC pUSA-ascF(mutant1)+ascE A . oryzae/ascABCEF(W130A, W131A)A . oryzae/ascABC pUSA-ascF(mutant2)+ascE A . oryzae/ascABCEF(W207A, W209A)A . oryzae/ascABC pUSA-ascF(mutant3)+ascE A . oryzae/ascABCEF(W228A) A . oryzae/ascABC pUSA-ascF(mutant4)+ascE",
        "S12",
        "Table S4. Primers used for cloning and mutagenesis study",
        "",
        "",
        "Table S5. Plasmids constructed for in vitro assay",
        "",
        "",
        "S13",
        "Table S6. NMR data of the isolated compounds",
        "",
        "",
        "1H NMR: 500 MHz, 13C NMR: 125 MHz (in CDCl3)",
        "",
        "S14",
        "",
        "",
        "1H NMR: 500 MHz, 13C NMR: 125 MHz (in CDCl3)",
        "",
        "S15",
        "",
        "",
        "1H NMR: 500 MHz, 13C NMR: 125 MHz (in CDCl3)",
        "",
        "S16",
        "",
        "",
        "Figure S1. Schematic representation and annotation of ascA-G",
        "Genes Amino acids (base pairs)Protein homologue, origin organismIdentities / SimilaritiesPredicted FunctionascA 2118 (6527)StbA, Stachybotrys bisbyi60% / 76%Polyketide synthase (PKS)ascB 1064 (3316)StbB, Stachybotrys bisbyi61% / 76%NRPS-like carboxylate reductaseascC 333 (1002)StbC, Stachybotrys bisbyi57% / 69%UbiA prenyltransferase (PT)ascD 560 (1995)AclH, Aspergillus oryzae RIB4057% / 72%Flavin-dependent halogenase (HLG)ascE 1069 (3535)AoCYP505A3, Aspergillus oryzae RIB4047% / 64%Cytochrome P450 / Cytochrome P450 reductase (P450/CPR)ascF 267 (894)AndB, Emericella variecolor30% / 49%Terpene cyclase (CYC)ascG 533 (1755)AtaF, Aspergillus terreus NIH262433% / 51%Cytochrome P450",
        "S17",
        "Figure S2. Sequence alignment between AscF, Pyr4, Trt1, AusL, AdrI, and AndB Red flames indicate the amino acids mutated into alanine in this work, black flames indicate catalytic acid and base residues identified in Pyr4 study (T. Itoh, K. Tokunaga, Y. Matsuda, I. Fujii, I. Abe, Y.",
        "Ebizuka, T. Kushiro, Nat. Chem., 2010, 2, 858\u2013864). Red and blue markers are transmembrane region predicted by TMHMM server. ",
        "AscF    1 MAFNDVPPPHVSPLYQ---PVYEATFGFAGLAWTLCYILYAREGLRTKSYGMPLFALANNFAWEMTYALYPyr4    1 MD-GWSDLSSAPPQYREVAGIADWALLAQGLGWSINYLAMIYHSYKDRTYGMAILPLCCNFAWEFVYSVITrt1    1 -------MPSIISDPQ---AYDIMLRLLQFSCWSLSYINTVRTTLSDQLPSVSFMSICCDVAWEFVYAFVAusL    1 MS--QLTISKIIEEPFSALSLSEMLKILAALGWSTNYLAMVYRTQADKLPAIAVLPLCCDIAWEFTYAWIAdrI    1 ME-KSTLLSAVLKHRDALASVAEFLRILAGICWTLNYFSMLRTSQKDKIPSTGIFPLCNDIGWEFIYAFIAndB    1",
        "----MQPITQIPLTFDT---VVNLLGSASGIGWILNYILMTYYSFRDKTYSMSMLPLCCNIAWEFVYGILAscF   68 V-ADAAREKTAMVIWMLIDIPIVYSLLRHGRNEWSHAPMVSR--NLGKIFVLLVALCATAHYSWASWWMGPyr4   70 YPSHNSAERAVLTTWMILNLFVMYTAIKFAPNEWQHAPLVRQ--CLPWIFPVAIAAFTAGHLALA-----Trt1   61 YPIASSHWAGGIRIWFAMHCVMLFIVAKYAPNDWDHVPLMKRF--ARLAYVAITIGFMAGHLALA-----AusL   69 YPQASGHWQGVVRVWFFLHTAVLAATLRYAPNDWAGTPLGESRGRLVLLYAAVIAAFAAGQLCLA-----AdrI   70 YPKASAHWEGGVRVWFLVHCIVIFFIIKNAHNEWDYFPLIQ--RNLYFLYGIVTIGFAIGQYSFA-----AndB   64",
        "CPSSTFVVRPVILSWLVLNCLVVYAAIKYSPNEWAHAPLVQR--HLPLLFTVGIAACTGFHIALI-----AscF  135 NGIAMKSGKSYRGVEGLDPTEMAFWAVSVCQVVVSTSSLAQLITRQHTGGVSWAVWA--LRFLGTFIGLNPyr4  133 --------------ATVGVSKAANWGAFLCFELLTSGAVCQLMSRGSSRGASYTIWL--SRFLGSYIGGITrt1  124 --------------SEIGPALGFFWSGALCQITASLGSLCLLVCRGSTRGASIKTWNSYFRIIATVGGFTAusL  134 --------------LEMGGALGFHWGGALCQFLSSSAAVGQLLTRGHTRGASLLIWG--ARAISTAGGFVAdrI  133 --------------REVGPDLGFFYGGVLCQTLASLGPIAQILSRNSTRGASLLTWL--LRAVATFGGFIAndB  127",
        "--------------RKFDPATAFLWSARSCQVLLSIGGLFQLLCRSSTKGGSYVLWL--SRFLGSICGVLAscF  203 ISYGWAWYTWPEAHAYFMSEPAIFLWGITTVCDIVYAIVFAKVRRNERVLEDGRKMAPRHEGKELPyr4  187 -FLHVRETHWPQEFGWISHPFVTWHGLMCFSLDIAYVTFLWRIRRQEHRSQRKKAL---------Trt1  180 -KMSIRHIWHLADEPWFDSPLCWFYIAITLTLDAIYPVFFFYFRAIEHPKKDSERKVE-------AusL  188 -KLCIRFQHQVDGAPWLDSPMCWFYIGIVLSLDASYPVLYQLTRRHEEASGGGKSGKVKNW----AdrI  187 -KLTIYYLTGNAAGPWFESPMCKFYIGLTLILDFTYPICYYVIRRQELVNDEGDKKKKTKSGKAAAndB  181",
        "-KMTLMWKYGESRFPWLDDPLTAYCIALWIISDVLYGVVFYSLRSKELAGAGKAKAI--------\u2248\u00e7",
        "W131,132",
        "W207,209 W228",
        "W128",
        "S18",
        "",
        "",
        "S19",
        "",
        "",
        "",
        "",
        "",
        "Figure S3. Comparison between AscE and P450 BM-3",
        "Alignment between AscE and P450 BM-3 (A), homology model of P450 domain (B) and",
        "flavin-NADP+ binding domain (C), and the reaction of P450 BM-3 (D) Heme, FAD, NADP+, and FMN binding sites of P450BM-38,9 were shown in the alignment. Homology model was built by Phyre2 server (http://www.sbg.bio.ic.ac.uk/phyre2/). The model of AscE P450 domain (1-462) (brown) was",
        "built by using the PDB model 4H23 (cyan) as a template, and that of flavin-NADP+ binding domain (504-1069) (brown) was built by using 1J9Z (cyan) as a template. ",
        "heme",
        "B)",
        "FAD",
        "FMN",
        "NADPH",
        "C)",
        "OH",
        "O(OH)",
        "(OH)",
        "(OH)",
        "OH",
        "O",
        "NADPH O2,",
        "H+NADP+ H2O",
        "54% 20%",
        "25%",
        "NADPH O2,",
        "H+NADP+ H2O",
        "O",
        "D)",
        "S20",
        "",
        "",
        "Figure S4. MS spectra of the compounds in this study",
        "",
        "S21",
        "",
        "Figure S5. UV spectra of the compounds isolated in this study",
        "S22",
        "",
        "Figure S6. SDS-PAGE analysis of the recombinant AscE and AscD",
        "From Rosetta2/pColdII-AscE (Lane2 & 4; insoluble & soluble fraction), negative control Rosetta2/pColdII (Lane1 & 3; insoluble & soluble fraction), Rosetta2/pET28a-AscD (Lane6; soluble fraction), and negative control Rosetta2/pET28a (Lane5; soluble fraction). Molecular weight of AscE is 120 kDa, and that of AscD is 63 kDa. M; Thermo Scientific PageRuler Prestained Protein Ladder (170, 130, 70 (purple), 55, 40, 35 kDa)",
        "",
        "",
        "",
        "",
        "Figure S7. Absorption spectra of the recombinant AscE",
        "Soluble fraction of Rosetta2/pColdII-AscE (B), and negative control Rosetta2/pColdII (A).",
        "",
        "1 2 3 4M",
        "[nm]",
        "[A u]",
        "[A u]",
        "[nm]",
        "Blue: +CORed:+CO,",
        "Na2S2O4Blue: +CORed:+CO,",
        "Na2S2O4A) B)",
        "S23",
        "",
        "Figure S8. 4 was hydrolyzed to 4\u2019 in SN2 manner.",
        "",
        "Figure S9. HPLC profile of in vitro assay of AscE by using 5-farnesyl-6-hydroxymellein as a substrate. Lane i shows a negative control, and lane ii shows complete reaction. The substrate (m/z = 397 [M-H]-) was converted into the product (m/z = 413 [M-H]-). The chromatograms were monitored at 295",
        "nm.",
        "",
        "(S)",
        "CHO",
        "OH",
        "HO",
        "O",
        "(R) CHO",
        "OH",
        "HO",
        "4 cylindrocarpol",
        "(4\u2019)HO",
        "OH",
        "OH-",
        "H+ SN2",
        "reaction12.5 15 17.5 20 22.5",
        "[min]",
        "OH",
        "OH",
        "O O",
        "+16",
        "i)",
        "ii)",
        "S24",
        "",
        "Figure S10. HPLC analysis of the AscF mutants in vitro assay. Percentage showed the consumption",
        "of substrate. UV absorbance was 295 nm.",
        "S25",
        "",
        "Figure S11. Phylogenetic tree analysis of meroterpenoid terpene cyclases",
        "Multiple sequence alignment, performed with ClustalW. The scale represents 0.10 amino acid substitutions per site. XiaH",
        "from Streptomyces sp. SCSIO 02999 was employed as out group. Accession numbers: AndB from Emericella variecolor, AtmB Aspergillus flavus, AusL Aspergillus nidulans FGSC A4, LtmB Epichloe festucae var. lolii, MacJ Penicillium terrestris, AdrI Penicillium chrysogenum, PaxM Penicillium paxilli,",
        "LtmB Epichloe festucae var. lolii, MacJ Penicillium terrestris, OclD Penicillium oxalicum 114-2, PaxB Penicillium paxilli, PrhH Penicillium brasilianum NBRC6234, Pyr4 Aspergillus fumigatus F37, Trt1 Aspergillus terreus, AscF Fusarium sp., Verruculide_cyclase Penicillium verruculosum, AFO69287 Periglandula ipomoeae, AFO69298 Epichloe",
        "O",
        "OH CO2CH3",
        "O",
        "O",
        "OH O",
        "OH",
        "O",
        "O O",
        "O",
        "O",
        "O H",
        "O",
        "OH",
        "O",
        "R",
        "HO",
        "CHO OH",
        "O",
        "O NO",
        "OH",
        "O",
        "HN",
        "O",
        "HN",
        "O",
        "A G N 7 3 0 0 3",
        "A G N 7 3 0 0 5",
        "A G N 7 3 0 0 6",
        "A G N 7 3 0 8 6",
        "A G N 7 3 0 0 7",
        "A F P 2 7 2 7 0",
        "A G N 7 3 0 0 4",
        "A G N 73 07 6",
        "A G N 73",
        "06 2",
        "A B F 20",
        "22 6",
        "Lt m B A FO",
        "69 29 8",
        "A FO",
        "69 28 7 AF",
        "O 69 30 5",
        "AF P2 72 92",
        "AF O 85 42 1",
        "OA",
        "A3 29 41",
        "KH N9 40 01 OA A3 48 64",
        "XP _0 07 81 32 80",
        "XP _0 07 81 62 70",
        "XP _01 457 371 0",
        "KF G8 037 6 XP_ 014 541 493",
        "KID 816 91 KJK7 4552 KFH4 4079 AGN73 002 KJZ73006 KJZ71105 KOM21072 KOS19956 BAM84047 ODA80718KYK60562",
        "BAU61559AGZ20190GAD99481",
        "CAK48315 XP_001394250 GAA83986KKK13519",
        "KKK13733",
        "CDM28239 CRL19196 KO S38981 PaxB E3U BL6 O C K 81419 A G Z20474 X P _001826324 X P _002378013 E IT 78655 A tm B A 9 JP E 3 X P _ 0 1 5 4 0 6 2 3 2 V e rru cu lid e _ cycla se",
        "G A O 8 9 4 6 5",
        "K JZ 8 0 3 3 8",
        "P yr4 X P _ 7 5 1 2 7 0",
        "K E Y 8 4 1 4 8",
        "G A Q 0 3 6 8 2",
        "X P _ 0 0 1 2 6 2 3 0 9 A n d B",
        "A 0 A 0 9 7 Z P D 8",
        "P rh H",
        "C E J6",
        "13 16 A us L",
        "C E L1",
        "12 71T rt 1 A dr I",
        "C D M 27 37 7",
        "X P _0 16 59 50 32",
        "KU",
        "L8 18 46",
        "CR",
        "L2 85 07",
        "KO",
        "M 20 73 2",
        "OB R0 97 84CE F7 96 29",
        "XP _0 11 32 09 86 EY B2 79 98",
        "XP _0 09 26 22 29KIL 841",
        "21",
        "EKG 137 29EXU 956 82KFG 8192 0 XP_0 07814 548XP_00 782368 6CEL0890 0",
        "GAQ05405",
        "GAO85985 EDP47980 GAO85956 GAQ05411 AscF",
        "GAQ34046",
        "GAA83664 XP_001389192 EHA26643",
        "MacJ Pc16g00320 XP_746967 KMK56825 KEY82996 XP_001261883",
        "O clD",
        "XiaH",
        "KIA75414 X P _681413 G A O 83049",
        "G A Q 09941",
        "X P _001259220 E D P 52188",
        "X P _753197",
        "K E Y 81846",
        "0.10",
        "O OH",
        "O",
        "R",
        "S26",
        "gansuensis, AFO69305 Aciculosporium take, AFO85421 Claviceps paspali, AFP27270 Epichloe festucae, AFP27292 Claviceps purpurea, AGN73002 Epichloe aotearoae, AGN73003 Epichloe occultans, AGN73004 Epichloe siegelii,",
        "AGN73005 Neotyphodium sp. FaTG-3, AGN73006 Neotyphodium sp. FaTG-2, AGN73007 Neotyphodium sp. FaTG-2, AGN73062 Epichloe funkii, AGN73076 Epichloe coenophiala, AGN73086 Neotyphodium sp. FaTG-4, AGZ20190 Penicillium crustosum, AGZ20474 Penicillium janthinellum, ABF20226 Epichloe festucae var. lolii, BAM84047",
        "Tolypocladium album, BAU61559 Penicillium simplicissimum, CAK48315 Aspergillus niger, CDM27377 Penicillium roqueforti FM164, CDM28239 Penicillium roqueforti FM164, CEF79629 Fusarium graminearum, CEJ61316 Penicillium brasilianum, CEL08900 Aspergillus calidoustus, CEL11271 Aspergillus calidoustus, CRL19196 Penicillium",
        "camemberti, CRL28507 Penicillium camemberti, EDP47980 Aspergillus fumigatus A1163, EDP52188 Aspergillus fumigatus A1163, EHA26643 Aspergillus niger ATCC 1015, EIT78655 Aspergillus oryzae 3.042, EKG13729 Macrophomina phaseolina MS6, EXU95682 Metarhizium robertsii, EYB27998 Fusarium graminearum, GAA83664",
        "Aspergillus kawachii IFO 4308, GAA83986 Aspergillus kawachii IFO 4308, GAD99481 Byssochlamys spectabilis No. 5, GAO83049 Aspergillus udagawae, GAO85956 Aspergillus udagawae, GAO85985 Aspergillus udagawae, GAO89465 Aspergillus udagawae, GAQ03682 Aspergillus lentulus, GAQ05405 Aspergillus lentulus, GAQ05411 Aspergillus",
        "lentulus, GAQ09941 Aspergillus lentulus, GAQ34046 Aspergillus niger, KEY81846 Aspergillus fumigatus var. RP-2014, KEY82996 Aspergillus fumigatus var. RP-2014, KEY84148 Aspergillus fumigatus var. RP-2014, KFG80376 Metarhizium anisopliae, KFG81920 Metarhizium anisopliae, KFH44079 Acremonium chrysogenum ATCC 11550,",
        "KHN94001 Metarhizium album ARSEF 1941, KIA75414 Aspergillus ustus, KID81691 Metarhizium guizhouense ARSEF 977, KIL84121 Fusarium avenaceum, KJK74552 Metarhizium anisopliae BRIP 53293, KJZ71105 Hirsutella minnesotensis 3608, KJZ73006 Hirsutella minnesotensis 3608, KJZ80338 Hirsutella minnesotensis 3608, KKK13519",
        "Aspergillus rambellii, KKK13733 Aspergillus ochraceoroseus, KMK56825 Aspergillus fumigatus Z5, KOM20732 Ophiocordyceps unilateralis, KOM21072 Ophiocordyceps unilateralis, KOS19956 Escovopsis weberi, KOS38981 Penicillium nordicum, KUL81846 Talaromyces verruculosus, KYK60562 Drechmeria coniospora, B6H6U3 Penicillium",
        "chrysogenum ATCC 28089, OAA32941 Aschersonia aleyrodis RCEF 2490, OAA34864 Metarhizium rileyi RCEF 4871, OBR09784 Colletotrichum higginsianum IMI 349063, OCK81419 Lepidopterella palustris CBS 459.81, ODA80718 Drechmeria coniospora, XP_681413 Aspergillus nidulans FGSC A4, XP_746967 Aspergillus fumigatus Af293,",
        "XP_751270 Aspergillus fumigatus Af293, XP_753197  Aspergillus fumigatus Af293, XP_001259220 Aspergillus fischeri NRRL 181, XP_001261883 Aspergillus fischeri NRRL 181, XP_001262309 Aspergillus fischeri NRRL 181, XP_001389192 Aspergillus niger CBS 513.88, XP_001394250 Aspergillus niger CBS 513.88, XP_001826324",
        "Aspergillus oryzae RIB40, XP_002378013 Aspergillus flavus NRRL3357, XP_007813280 Metarhizium acridum CQMa 102, XP_007814548 Metarhizium acridum CQMa 102, XP_007816270 Metarhizium robertsii ARSEF 23, XP_007823686 Metarhizium robertsii ARSEF 23, XP_009262229 Fusarium pseudograminearum CS3096,",
        "XP_011320986 Fusarium graminearum PH-1, XP_014541493 Metarhizium brunneum ARSEF 3297, XP_014573710 Metarhizium majus ARSEF 297, XP_015406232 Aspergillus nomius NRRL 13137, XP_016595032 Penicillium expansum",
        "S27",
        "",
        "Figure S12. HPLC analysis of the product accumulated in A. oryzae/AscABCE i), A. oryzae/AscABCEF ii), W127A iii), W130A/W131A iv), W207A/W209A v), W228A vi). UV",
        "absorbance was 295 nm. The compound labeled as * is an unidentified compound which has UVmax at 272 and 282 nm.",
        "S28",
        "",
        "Figure S13. HPLC analysis of the products accumulated in A. oryzae/AscABCEF i), AscABCDEF",
        "incubated with KCl ii), incubated with KBr iii). UV absorbance was 295 nm.",
        "",
        "Figure S14. HPLC analysis of the products accumulated in Fusarium sp. incubated without any halogen source i) with KCl ii), with KBr iii). UV absorbance was 295 nm.",
        "S29",
        "",
        "Figure S15. HPLC profile of AscD in vitro assay. 2 was incubated with soluble protein extract from Rosetta2/pET28a-AscD i), and the extract from Rosetta2/pET28 ii), and 5 was incubated with soluble protein extract from Rosetta2/pET28a-AscD iii), and the extract from Rosetta2/pET28 iv). The chromatograms were monitored at 295 nm. ",
        "",
        "",
        "Figure S16. The biosynthetic pathway of ascofuranone (A) and putative pathway of",
        "siccanochromenic acid (B)",
        "",
        "",
        "OH",
        "O",
        "COOHOH",
        "HO",
        "COOH",
        "H",
        "H+",
        "OH",
        "HO",
        "COOH",
        "OH",
        "HO",
        "CHOO",
        "O Cl",
        "OH",
        "HO",
        "CHOO",
        "HO Cl",
        "H+",
        "OH",
        "HO",
        "CHOHO",
        "O",
        "OH",
        "HO",
        "CHO",
        "O OH",
        "OH",
        "HO",
        "CHO",
        "O",
        "ascofuranol ascofuranone",
        "siccanochromenic",
        "acidA)",
        "B)",
        "Cl Cl Cl",
        "S30",
        "",
        "Figure S17. Comparison of terpene cyclization between ascochlorin and stachybotrydial",
        "",
        "HO",
        "HO",
        "CHO",
        "O H+",
        "HO",
        "HO",
        "CHO",
        "HO",
        "H",
        "HO",
        "CHO",
        "CHO",
        "O",
        "HO",
        "stachybotrydial",
        "A)",
        "B)",
        "OH",
        "HO",
        "O",
        "CHO",
        "HO",
        "HO",
        "CHO",
        "HO",
        "HO",
        "HO",
        "CHO",
        "O",
        "H+",
        "OH",
        "HO",
        "CHOO",
        "Cl",
        "Cl Cl",
        "S31",
        "",
        "Figure S18. 1H NMR spectrum of ascochlorin (1a)",
        "",
        "Figure S19. 13C NMR spectrum of ascochlorin (1a)",
        "",
        "",
        "OH",
        "HO",
        "CHOO",
        "Cl",
        "",
        "OH",
        "HO",
        "CHOO",
        "Cl",
        "S32",
        "",
        "Figure S20. 1H NMR spectrum of 3-bromoascochlorin (1b)",
        "",
        "Figure S21. 13C NMR spectrum of 3-bromoascochlorin (1b)",
        "",
        "",
        "OH",
        "HO",
        "CHOO",
        "Br",
        "",
        "OH",
        "HO",
        "CHOO",
        "Br",
        "S33",
        "",
        "Figure S22. 1H NMR spectrum of dechloroascochlorin (6)",
        "",
        "Figure S23. 13C NMR spectrum of dechloroascochlorin (6)",
        "",
        "",
        "OH",
        "HO",
        "CHOO",
        "",
        "OH",
        "HO",
        "CHOO",
        "S34",
        "",
        "Figure S24. 1H NMR spectrum of 12,13-dihydroascochlorin (7a)",
        "",
        "Figure S25. 13C NMR spectrum of 12,13-dihydroascochlorin (7a)",
        "",
        "",
        "OH",
        "HO",
        "CHOO",
        "Cl",
        "",
        "OH",
        "HO",
        "CHOO",
        "Cl",
        "S35",
        "",
        "Figure S26. 1H NMR spectrum of 3-bromo-12,13-dihydroascochlorin (7b)",
        "",
        "Figure S27. 13C NMR spectrum of 3-bromo-12,13-dihydroascochlorin (7b)",
        "",
        "",
        "OH",
        "HO",
        "CHOO",
        "Br",
        "",
        "OH",
        "HO",
        "CHOO",
        "Br",
        "S36",
        "",
        "Figure S28. 1H NMR spectrum of dechloro-12,13-dihydroascochlorin (5)",
        "",
        "Figure S29. 13C NMR spectrum of dechloro-12,13-dihydroascochlorin (5)",
        "",
        "",
        "OH",
        "HO",
        "CHOO",
        "",
        "OH",
        "HO",
        "CHOO",
        "S37",
        "",
        "Figure S30. 1H NMR spectrum of LL-Z1272\u03b2 (2)",
        "",
        "Figure S31. 13C NMR spectrum of LL-Z1272\u03b2 (2)",
        "",
        "0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.013.5",
        "f1",
        "(ppm)6 .2 0 3 .1 8 3 .1 4 8 .6 7 3 .1 2",
        "2 .0 9",
        "2 .0 9 1 .0 5",
        "1 .0 2",
        "0 .9 9",
        "1 .0 0",
        "1 .5 9 1 .5 9 1 .6 7 1 .6 7 1 .8 2 1 .9 4 1 .9 6 1 .9 7 2 .0 2 2 .0 3 2 .0 4 2 .0 6 2 .0 7 2 .0 9 2 .1 1 2 .1 2 2 .1 4 2 .4 7 3 .3 9 3 .4 0 5 .0 6 5 .0 7 5 .0 8 5 .0 8 5 .0 9 5 .0 9 5 .2 6 5 .2 6 5 .2 7 5 .2 7 5 .2 9 5 .2 9 6 .2 2",
        "1 0 .0 2",
        "1 2 .6 8",
        "0102030405060708090100110120130140150160170180190200",
        "f1",
        "(ppm)1 6 .0 8 1 6 .2 7 1 7 .7 2 1 8 .0 2 2 1 .2 3 2 5 .7 4 2 6 .3 7 2 6 .7 2 3 9 .7 1 3 9 .7 6",
        "1 1 0 .9 6 1 1 2 .1 9 1 1 3 .1 8 1 2 1 .1 6 1 2 3 .7 2 1 2 4 .4 7 1 3 1 .2 9 1 3 5 .5 3 1 3 8 .7 4 1 4 2 .1 2",
        "1 6 2 .8 8 1 6 3 .8 9",
        "1 9 3 .0 4",
        "",
        "OH",
        "HO",
        "CHO",
        "",
        "OH",
        "HO",
        "CHO",
        "S38",
        "",
        "Figure S32. 1H NMR spectrum of cylindrocarpol (4\u2019)",
        "",
        "Figure S33. 13C NMR spectrum of cylindrocarpol (4\u2019)",
        "",
        "",
        "OH",
        "HO",
        "CHOHO",
        "OH",
        "",
        "OH",
        "HO",
        "CHOHO",
        "OH",
        "S39",
        "",
        "Figure S34. 1H NMR spectrum of 4-O-methylated-4\u2019",
        "",
        "Figure S35. COSY spectrum of 4-O-methylated-4\u2019",
        "",
        "",
        "OH",
        "O",
        "CHOHO",
        "OH",
        "S40",
        "",
        "Figure S36. HMQC spectrum of 4-O-methylated-4\u2019",
        "",
        "Figure S37. HMBC spectrum of 4-O-methylated-4\u2019",
        "",
        "S41",
        "",
        "Figure S38. Key HMBC correlation of 4-O-methylated-4\u2019",
        "",
        "S42",
        "",
        "Figure S39. 1H NMR spectra of S-mosher diester of 4-O-methylated-4\u2019",
        "",
        "Figure S40. COSY spectrum of S-mosher diester of 4-O-methylated-4\u2019",
        "",
        "5 4 3 2 1 6 8 OO",
        "7 H",
        "9 10 O 11 12 13 14 15 16 17 18 (R) 1920",
        "232221",
        "O",
        "HO",
        "(S) O",
        "S-mosher",
        "CF3 OCH3",
        "(S) OH3CO",
        "F3C",
        "S43",
        "",
        "Figure S41. 1H NMR spectrum of R-mosher diester of 4-O-methylated-4\u2019",
        "",
        "",
        "Figure S42. COSY spectrum of R-mosher diester of 4-O-methylated-4\u2019",
        "",
        "5 4 3 2 1 6 8 OO",
        "7 H",
        "9 10 O 11 12 13 14 15 16 17 18 (R) 1920",
        "232221",
        "O",
        "HO",
        "(R) O",
        "R-mosher",
        "OCH3 CF3",
        "(R) OF3C",
        "H3CO",
        "S44",
        "Supplementary References",
        "1. Chooi, Y.-H.; Cacho, R.; Tang, Y., Identification of the viridicatumtoxin and griseofulvin gene clusters from Penicillium",
        "aethiopicum. Chemistry & biology 2010, 17, 483-494. 2. Jin, F. J.; Maruyama, J.-i.; Juvvadi, P. R.; Arioka, M.; Kitamoto, K., Development of a novel quadruple auxotrophic host transformation system by argB gene disruption using adeA gene and exploiting adenine auxotrophy in Aspergillus oryzae.",
        "FEMS microbiology letters 2004, 239, 79-85. 3. Kubodera, T.; Yamashita, N.; Nishimura, A., Transformation of Aspergillus sp. and Trichoderma reesei using the pyrithiamine resistance gene (ptrA) of Aspergillus oryzae. Bioscience, biotechnology, and biochemistry 2002, 66, 404-406.",
        "4. Matsuda, Y.; Wakimoto, T.; Mori, T.; Awakawa, T.; Abe, I., Complete biosynthetic pathway of anditomin: nature\u2019s sophisticated synthetic route to a complex fungal meroterpenoid. Journal of the American Chemical Society 2014, 136, 15326-15336.",
        "5. Gomi, K.; Iimura, Y.; Hara, S., Integrative transformation of Aspergillus oryzae with a plasmid containing the Aspergillus nidulans argB gene. Agricultural and biological chemistry 1987, 51, 2549-2555. 6. Arkoudis, E.; Stratakis, M., Synthesis of cordiaquinones B, C, J, and K on the basis of a bioinspired approach and the",
        "revision of the relative stereochemistry of cordiaquinone C. The Journal of organic chemistry 2008, 73, 4484-4490. 7. Zhang, X.; Archelas, A.; Furstoss, R., Microbial transformationsd. 19. Asymmetric dihydroxylation of the remote double bond of geraniol: a unique stereochemical control allowing easy access to both enantiomers of geraniol-6, 7-diol. The",
        "Journal of Organic Chemistry 1991, 56, 3814-3817. 8. Oulos, T. H. L. P. Structure of a Cytochrome P450 \u2013 Redox Partner Electron-Transfer Complex. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 1863\u20131868.",
        "9. Joyce, M. G.; Ekanem, I. S.; Roitel, O.; Dunford, A. J.; Neeli, R.; Girvan, H. M.; Baker, G. J.; Curtis, R. A.; Munro, A. W.; Leys, D. The Crystal Structure of the FAD/NADPH-Binding Domain of Flavocytochrome P450 BM3. FEBS J. 2012, 279, 1694\u20131706.",
        "",
        ""
    ]
}